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7ABBREVIATIONS
APA American Psychiatric Association
BZ Bezugsziffern
CATCH-22 Acronym for the principal features of the velo-cardio-facial syndrome: 
Cardiac defects, Abnormal facies, Thymic hypoplasia, Cleft lip and/or 
palate, Hypocalcemia, and chromosome 22q11 deletion
CI Confidence interval
CNS Central nervous system
CSF Cerebrospinal fluid
DNA Deoxyribonucleic acid
DSM Diagnostic and Statistical Manual of Mental Disorders
GABA Gamma-aminobutyric acid
HLA Human leucocyte antigen
ICD International Classification of Diseases
Lod Logarithm of the odds
MR Morbid risk
PSE Present State Examination
RDC Research Diagnostic Criteria
RNA Ribonucleic acid
RR Relative risk
SD Standard deviation
STL Seasonal and Trend decomposition using Locally weighted regression
UKKI The Uusikaupunki-Kemijärvi Study
WHO World Health Organization
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2. INTRODUCTION
Schizophrenia occurs worldwide and is among the most severe mental disorders. Its
aetiology remains unknown, although both genetic and environmental risk factors are
known to be involved. Its pathophysiology is also largely obscure, and consequently the
available treatment can alleviate symptoms but not cure the disease. The enormous
psychological and social distress schizophrenia causes and the limited means available
for helping its sufferers means that its aetiology and pathophysiology are among the
most extensively studied of the mental disorders. (Schultz & Andreasen 1999)
Schizophrenia appears to be more prevalent in Finland than in most other western
countries (Torrey 1987, Lehtinen et al 1990, Hovatta et al 1997), and is a leading cause
of disability retirement there, particularly among the population aged 16 to 44 years
(KELA 1996). ”The Genetic Epidemiology and Molecular Genetics of Schizophrenia in
Finland” project, initiated in 1988, is a collaborative venture of the Department of
Mental Health and Alcohol Research and the Department of Human Molecular Genetics
of the National Public Health Institute. The aim of the project is to identify genetic and
environmental factors predisposing to schizophrenia. The current thesis forms part of
that project.
2.1. Evolution of the diagnostic concept of schizophrenia
2.1.1. Kraepelin
The disease entity nowadays called schizophrenia was first delineated by Emil
Kraepelin (1856-1926) in 1893 (Harms 1971). Kraepelin used the name dementia
praecox for the disease to stress its early onset and the permanent deterioration of
mental functioning it causes among the great majority of patients. He defined dementia
praecox as ”a series of states, the common characteristic of which is a peculiar
destruction of the internal connections of the psychic personality. The effects of this
injury predominate in the emotional and volitional spheres of mental life". (Kraepelin
1919, p. 3).
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Kraepelin detailed the symptoms commonly occurring in schizophrenia (Table 1), the
most fundamental features of which were the weakening of volition and emotional
dullness, which cause mental activities to decline, and the loss of inner unity of the
activities of intellect, emotion and volition, which causes incoherence in thinking and
action and inappropriate affect. However, he considered no symptom as pathognomonic
for schizophrenia. (Kraepelin 1919, pp. 11-73 and 257)
Originally, Kraepelin divided dementia praecox into three clinical subtypes:
hebephrenic, catatonic, and paranoid. He later elaborated this subtyping to include
several other categories, while emphasizing that the subgrouping of different clinical
pictures was rather artificial and of limited clinical value. (Kraepelin 1919, pp. 89-180)
Kraepelin was also the first to formulate the concept of manic-depressive insanity. In
distinguishing this from dementia praecox, he did not consider any single symptom as
characteristic of either disease, but stressed the importance of evaluating the whole
clinical picture. The symptoms suggestive of dementia praecox in the presence of
affective symptoms were lack of inner logical arrangement of mental events, early
appearance of numerous auditory hallucinations, bizarre delusions, delusions of
influence on will, and incoherent speech. Symptoms more suggestive of manic-
depressive illness were a tendency to, and ability for, observation of self, and periodic
course with complete restoration of psychic and social functioning in between.
Disorders characterized by delusions and hallucinations in which disorders of emotion
and volition did not exist or were minimal were referred to by Kraepelin as
paraphrenias. Although these had many features in common with the paranoid form of
dementia praecox, Kraepelin considered that the well-preserved mental activities and
absence of disorders of volition justified the classification of paraphrenias into a
separate disease entity. (Kraepelin 1919, pp. 260-328)
13
Table 1. Symptoms of dementia praecox according to Kraepelin
1. Hallucinations
A. Auditory hallucinations
• Unpleasant voices
• Voices that comment on the thoughts and doings of the patient
• Commanding voices
• Patient’s own thoughts spoken aloud
B. Tactile hallucinations
• Somatic
• Sexual
C. Hallucinations of smell and taste
2. Delusions
• Delusions of influence
• Delusions of persecution
• Grandiose delusions
• Sexual delusions
• Ideas of reference
3. Incoherence of thought and speech
• Stereotypy of speech
• Poverty of speech
• Mutism
• Neologisms
4. Catatonic symptoms
• Automatic obedience
• Echolalia and echopraxia
• Stereotypy of movement
• Catatonic excitement
• Mannerisms
• Negativism
5. Disordered attention
6. Disordered judgement
7. Emotional dullness
8. Avolition
9. Autism
(Kraepelin 1919)
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2.1.2. Bleuler
Unlike Kraepelin, Eugen Bleuler (1857-1939) did not emphasize poor outcome in
diagnosing schizophrenia. It had also become more evident since Kraepelin introduced
the concept of dementia praecox that the disorder did not always begin in adolescence
or early adulthood. Thus, Bleuler suggested that the name of the disease be changed to
”schizophrenia” because of the characteristic disintegration of various mental functions.
(Bleuler 1911, pp. 7-8)
Bleuler divided symptoms of schizophrenia into fundamental symptoms, which he
considered as characteristic of schizophrenia and present in every patient and at every
period of the disease, and accessory symptoms, which may dominate the clinical picture
but may also be completely absent and are not pathognomonic for schizophrenia
(Bleuler 1911, p. 13). The fundamental symptoms (Table 2) were disturbances of
association, affectivity and attention, ambivalence, and autism. Bleuler also regarded the
absence of primary disturbances of perception, orientation and memory as fundamental
to schizophrenia. Some other features of the disease, such as lack of will, disturbed
behaviour, and disorders in intelligence, were considered to be a consequence of these
fundamental symptoms. The severity of the fundamental symptoms in individual
patients may vary from ”a maximum which corresponds to complete confusion to a
minimum which may be hardly noticeable”. Bleuler regarded delusions, hallucinations,
and catatonic symptoms as accessory symptoms, although he admitted that it is often
because of them that patients come to psychiatric treatment. (Bleuler 1911, pp. 14-226)
The diagnosis of schizophrenia was based on the presence of fundamental symptoms,
though not all of them needed to be apparent in a given patient. The duration of
symptoms and the outcome of the illness were not emphasized in diagnosing the
disorder. Although Bleuler did not consider outcome important, he stated that ”As yet I
have never released a schizophrenic in whom I could not still see distinct signs of the
illness; indeed there are very few in whom one would have to search for such signs.”
(Bleuler 1911, p. 256)
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Bleuler divided schizophrenia into four subgroups: paranoid, catatonic, hebephrenic and
simple type. Paranoid type was characterized by the presence of prominent delusions
and hallucinations and included, besides paranoid forms of dementia praecox, the
majority of patients Kraepelin would have diagnosed as suffering from paraphrenia.
Various catatonic symptoms dominated the clinical picture in the catatonic type.
Hebephrenic type consisted of all the other patients who had, at some point in their
illness, exhibited acute psychotic symptoms and subsequently deteriorated but who did
not present with paranoid or catatonic characteristics. Simple schizophrenia consisted of
patients who gradually deteriorate affectively and intellectually without exhibiting other
prominent symptoms. (Bleuler 1911, pp. 227-238)
Table 2. Fundamental symptoms of schizophrenia according to Bleuler
1. Association
• Lack of purpose or goal in the speech; poverty of ideas
• Thought condensations
• Stereotypy; echolalia
• Thought blocking
• Pressure of thoughts; clang associations
2. Affectivity
• Lack of depth to the affect; restricted affect
• Lack of consistency of affective manifestation
• Inappropriate or blunted affect
3. Attention
• Lack of selectivity of attention; impaired active attention
4. Ambivalence
• Affective ambivalence: the same concept is accompanied simultaneusly by
pleasant and unpleasant feelings
• Ambivalence of will: the patient wishes and does not wish the same thing at the
same time
• Intellectual ambivalence: the patient expresses contradictory thoughts in the
same sentence
5. Autism
(Bleuler 1911)
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2.1.3. Schneider
Kurt Schneider (1887-1967) aimed at identifying signs and symptoms that would be
highly discriminating for schizophrenia and would be easily perceived by the treating
physician (Carpenter et al 1973, Andreasen & Carpenter 1993). The symptoms he chose
as characteristic of schizophrenia were quite different from the fundamental symptoms
of Bleuler. He identified a group of delusions and hallucinations which he believed to
be pathognomonic for schizophrenia and called these symptoms ”first-rank symptoms”
(Table 3) (Carpenter et al 1973). Other symptoms which occurred frequently in
schizophrenia but were not pathognomonic for it were called second-rank symptoms.
Schneider's diagnostic concept of schizophrenia has had considerable influence on
almost all diagnostic systems subsequently developed.
Table 3. First-rank symptoms of schizophrenia according to Schneider
• Audible thoughts
• Voices arguing or discussing, or both
• Commenting voices
• Somatic passivity experiences
• Thought withdrawal and other experiences of influenced thought
• Thought broadcasting
• Delusional perception
• Made impulses, thoughts, or volitional acts
(Carpenter et al 1973)
2.1.4. International Classification of Diseases, Eighth Revision
The International Classification of Diseases is a disease classification system developed
by the World Health Organization to promote international comparability of health care
statistics. The eighth revision of the International Classification of Diseases (ICD-8),
launched in 1967, placed considerable emphasis on Schneiderian first-rank symptoms in
its description of schizophrenia (WHO 1967). It included seven subtypes of
schizophrenia. The simple type was characterized by oddities of conduct, difficulties in
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social relationships, and decline in overall performance but without clear-cut symptoms
of schizophrenia. Typical symptoms of the hebephrenic type were inappropriate affect,
bizarre or catatonic behaviour, and prominent thought disorder. The catatonic type was
characterized by catatonic symptoms, and the paranoid type by prominent delusions and
hallucinations. In the acute schizophrenic episode, the onset of schizophrenic symptoms
was acute, and a dream-like state with slight clouding of consciousness and perplexity
was often present. The latent type was characterized by the emergence of symptoms not
obviously schizophrenic but severe enough to raise a strong suspicion of schizophrenia.
The residual type was reserved for chronic residual states in which fragments of faded
schizophrenic symptomatology occurred. In addition, ”other” and ”unspecified” types
were reserved for patients that did not fit into other subtypes. Infantile autism was
regarded as a part of schizophrenia. (WHO 1967, General Register Office 1968)
2.1.5. Diagnostic and Statistical Manual of Mental Disorders, Second Edition
The second edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-
II), published in 1968, gave a Bleulerian definition of schizophrenia, broader than the
ICD-8 definition. According to DSM-II, the mental state in schizophrenia was primarily
attributable to a thought disorder, which may lead to misinterpretation of reality and
sometimes to delusions and hallucinations.The subtyping of schizophrenia was similar
to ICD-8, except that an eighth, childhood type, was included. (APA 1968)
2.1.6. Washington University Criteria (Feighner Criteria)
The Washington University or St. Louis or Feighner Criteria, published in 1972,
represented the first diagnostic classification validated primarily by follow-up and
family studies, rather than by clinical judgement and experience (Feighner et al 1972).
Feighner Criteria were also the first to assign operational diagnostic criteria to each
disorder they include. The diagnostic criteria for schizophrenia emphasized poor
premorbid functioning, chronicity of the disorder, and absence of affective symptoms
(Table 4). Subtyping was not included. Of the commonly used diagnostic criteria for
schizophrenia, Feighner’s criteria are the most restrictive (Hill 1996, McGorry 1992).
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Table 4. The Washington University Criteria (Feighner Criteria) for schizophrenia
For a diagnosis of schizophrenia, A through C are required:
A. Both of the following are necessary:
1. A chronic illness with at least six months of symptoms prior to the index evaluation
without return to the premorbid level of psychosocial adjustment.
2. Absence of a period of depressive or manic symptoms sufficient to qualify for
affective disorder or probable affective disorder.
B. The patient must have at least one of the following:
1. Delusions or hallucinations without significant perplexity or disorientation associated
with them.
2. Verbal production that makes communication difficult because of a lack of logical or
understandable organization. (In the presence of muteness the diagnostic decision must
be deferred.)
C. At least three of the following manifestations must be present for a diagnosis of
”definite” schizophrenia, and two for a diagnosis of ”probable” schizophrenia.
1. Single
2. Poor premorbid social adjustment or work history
3. Family history of schizophrenia
4. Absence of alcoholism or drug abuse within one year of onset of psychosis
5. Onset of illness prior to age 40
(Feighner et al 1972)
Patients who fulfill the diagnostic criteria for primary affective disorder but in addition
have ”a massive or peculiar alteration of perception and thinking as a major
manifestation of their illness” do not have any diagnostic class in Feighner classification
but are classified as having an undiagnosed psychiatric disorder.
2.1.7. Research Diagnostic Criteria
The Research Diagnostic Criteria (RDC), introduced in 1975, were modified and
expanded from the Feighner Criteria. The diagnostic criteria of schizophrenia, however,
changed significantly. The requirement of illness duration shortened from 6 months to 2
weeks. Schneider’s first rank symptoms were given considerable weight in the
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diagnosis, while social and occupational functioning, age at onset, and family history
lost their significance (Table 5). (Spitzer et al 1978)
Table 5. Research Diagnostic Criteria for schizophrenia
A. During an active phase of the illness at least two of the following are required for
definite and one for probable diagnosis of schizophrenia:
1. Thought broadcasting, insertion, or withdrawal
2. Delusions of being controlled or influenced, other bizarre delusions, or multiple
delusions
3. Somatic, grandiose, religious, nihilistic, or other delusions without persecutory or
jealous content lasting at least one week
4. Delusions of any type if accompanied by hallucinations of any type for at least one
week
5. Auditory hallucinations in which either a voice keeps up a running commentary on
the subject’s behaviors or thoughts as they occur, or two or more voices converse with
each other.
6. Non-affective verbal hallucinations spoken to the subject
7. Hallucinations of any type throughout the day for several days or intermittently for at
least one month
8. Definite instances of marked formal thought disorder (as defined in this manual)
accompanied by either blunted or inappropriate affect, delusions or hallucinations of
any type, or grossly disorganized behavior.
B. Signs of the illness have lasted at least two weeks from the onset of a noticeable
change in the subject’s usual condition.
C. At no time during the active period of illness being considered has the subject met
the full criteria for either probable or definite manic or depressive syndrome to such a
degree that it was a prominent part of the illness.
(Spitzer et al 1978)
RDC included five subtypes of schizophrenia. Prominent symptoms of each type were:
delusions and/or hallucinations in the paranoid type, marked formal thought disorder
and inappropriate or blunted affect or not well-organized delusions or hallucinations in
the disorganized type, and catatonic symptoms in the catatonic type. The
undifferentiated type was reserved for periods of illness that met the criteria for more
than one subtype or none of them, and the residual type was used when psychotic
symptoms were no longer prominent but residual symptoms prevailed. The mood
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disorder exclusion criteria remained as strict as in the Feighner criteria. For those
patients that met the criteria for a manic or depressive syndrome but in addition had at
least one symptom indicative of schizophrenia, a new diagnostic class, schizoaffective
disorder, emerged. Schizoaffective disorder was a broad class, including forms in which
schizophrenic symptoms were of brief duration compared with the duration of affective
symptoms, or vice versa. It required the presence of only one symptom suggestive of
schizophrenia. This very broad definition of schizoaffective disorder was constructed to
help researchers ”purify” samples of patients with schizophrenia or affective disorder by
separating out those presenting mixed symptomatology. (Spitzer et al 1978)
2.1.8. International Classification of Diseases, Ninth Edition
In the ninth edition of the International Classification of Diseases, published in 1977
(WHO 1977), the description of schizophrenia had hardly changed from ICD-8.
However, childhood type schizophrenia and infantile autism were removed from
schizophrenic psychoses. Simple and latent schizophrenia remained in the classification,
but their use was discouraged (WHO 1978).
2.1.9. Diagnostic and Statistical Manual for Mental Disorders, Third Edition
After five years of development and field trials involving over 800 clinicians, DSM-III
was launched in 1980. DSM-III differed from previous internationally used diagnostic
classifications such as DSM-II and ICD-9 in that operational diagnostic criteria were
provided for each disorder, and from RDC and Feighner criteria in that all diagnostic
classes were included. (Spitzer et al 1980)
The diagnostic criteria for schizophrenia in DSM-III were a mixture of Feighner and
RDC criteria (Table 6). As in Feighner criteria, a 6-month duration of symptoms and
deterioration from a premorbid level of functioning were required. However,
Schneiderian first-rank symptoms were given considerable weight, as in the RDC
criteria. The concept of schizophrenia was narrower than that applied in the DSM-II and
ICD-9. DSM-II and ICD-9 diagnoses of simple and latent type were omitted and would
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usually correspond to a severe form of schizotypal or borderline personality disorder in
DSM-III. Some individuals diagnosed with schizophrenia in DSM-II and ICD-9
because of the concurrence of Schneiderian first-rank symptoms with symptoms of
major affective disorder would be diagnosed as suffering from an affective disorder in
DSM-III. DSM-III provided an explicit age-at-onset criterion: the onset of at least
prodromal symptoms must occur before 45 years. The subtypes of schizophrenia were
identical to those used in RDC: disorganized, catatonic, paranoid, undifferentiated, and
residual. A diagnosis of schizophreniform disorder was given when all other diagnostic
criteria for schizophrenia except the duration were fulfilled. Schizoaffective disorder
was the only diagnosis in DSM-III for which diagnostic criteria were not provided,
because a consensus committee found it impossible to agree on the criteria. (APA 1980,
Spitzer et al 1980, Skodol & Spitzer 1982, Williams & Spitzer 1982)
2.1.10. Diagnostic and Statistical Manual for Mental Disorders, Third Edition,
Revised
The diagnostic criteria for schizophrenia in the revised version of DSM-III
(DSM-III-R), launched in 1987, changed in a few noteworthy ways. Most obviously,
the age at onset criterion was omitted. A time duration of at least one week, or less if
successfully treated, was set for the acute phase symptoms. First-rank symptoms were
slightly less significant than in DSM-III. A criterion for schizophrenia in the presence of
autistic disorder was added. More explicit mood and schizoaffective disorder exclusion
criteria were given, because DSM-III-R included diagnostic criteria for schizoaffective
disorder. The subtyping of schizophrenia remained identical to that used in DSM-III.
(APA 1987)
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Table 6. DSM-III criteria for schizophrenia
A. At least one of the following during a phase of the illness:
1. Bizarre delusions, such as delusions of being controlled, thought broadcasting,
thought insertion, or thought withdrawal.
2. Somatic, grandiose, religious, nihilistic, or other delusions without persecutory or
jealous content.
3. Delusions with persecutory or jealous content if accompanied by hallucinations of
any type.
4. Auditory hallucinations in which either a voice keeps up a running commentary on
the individual’s behaviour or thoughts, or two or more voices converse with each other.
5. Auditory hallucinations on several occasions with content of more than one or two
words, having no apparent relation to depression or elation.
6. Incoherence, marked loosening of associations, markedly illogical thinking, or
marked poverty of content of speech if associated with at least one of the following:
(a) blunted, flat, or inappropriate affect
(b) delusions or hallucinations
(c) catatonic or other grossly disorganized behaviour
B. Deterioration from a previous level of functioning in such areas as work, social
relations, and self-care.
C. Duration: Continuous signs of the illness for at least six months at some time during
the person’s life, with some signs of the illness at present. The six-month period must
include an active phase during which there were symptoms from A, with or without a
prodromal or residual phase.
D. The full depressive or manic syndrome, if present, developed after any psychotic
symptoms, or was brief in duration relative to the duration of the psychotic symptoms in
A.
E. Onset of prodromal or active phase of the illness before age 45.
F. Not due to any organic mental disorder or mental retardation.
(APA 1980)
2.1.11. International Classification of Diseases, Tenth Edition
The tenth edition of the International Classification of Diseases (ICD-10) was published
in 1992. It is the first ICD edition to provide operationalized diagnostic criteria for
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research purposes. It is therefore more meaningful to compare the criteria for
schizophrenia (Table 7) with DSM-III-R criteria than with the previous ICD versions.
Table 7. ICD-10 Diagnostic Criteria for Research for schizophrenia
I. Either at least one of the syndromes, symptoms, and signs listed under 1. below, or at
least two of the symptoms and signs listed under 2. should be present for most of the
time during an episode of psychotic illness lasting for at least 1 month (or at some time
during most of the days):
1. At least one of the following must be present:
a) Thought echo, thought insertion or withdrawal, or thought broadcasting
b) Delusions of control, influence, or passivity, clearly referred to body or limb
movements or specific thoughts, actions, or sensations; delusional perception
c) Hallucinatory voices giving a running commentary on the patient’s behaviour, or
discussing the patient among themselves, or other types of hallucinatory voices coming
from some part of the body
d) Persistent delusions of other kinds that are culturally inappropriate and completely
impossible
2. Or at least two of the following:
a) Persistent hallucinations in any modality, when occurring every day for at least 1
month, when accompanied by delusions without clear affective content, or by persistent
over-valued ideas
b) Neologisms, breaks, or interpolations in the train of thought, resulting in incoherence
or irrelevant speech
c) Catatonic behaviour, such as excitement, posturing, or waxy flexibility, negativism,
mutism, or stupor
d) ”Negative” symptoms, such as marked apathy, paucity of speech, and blunting or
incongruity of emotional responses
II. Exclusion clauses:
1. If the patient also meets criteria for manic episode or depressive episode, the criteria
listed under I(1.) and I(2.) above must have been met before the disturbance of mood
developed
2. The disorder is not attributable to organic brain disease, or to alcohol- or drug-related
intoxication, dependence, or withdrawal
(WHO 1993)
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The required duration of symptoms is considerably shorter in ICD-10 than in
DSM-III-R, one vs. six months, and ICD-10 does not require deterioration from a
premorbid level of functioning. The mood disorder exclusion criterion in ICD-10
requires that the onset of psychotic symptoms must have preceded the onset of mood
symptoms, while DSM-III-R requires that the total duration of all episodes of a mood
syndrome has been brief relative to the total duration of the active and residual phases
of the disturbance. ICD-10 gives considerable weight to Schneiderian first-rank
symptoms, but is also the first diagnostic classification to include negative symptoms.
ICD-10 includes the DSM-III-R subtypes, paranoid, disorganized, catatonic,
undifferentiated, and residual. In addition, simple schizophrenia is retained from ICD-9.
(WHO 1993)
2.1.12. Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition
The fourth edition of the Diagnostic and Statistical Manual for Mental Disorders was
published in 1994. The largest difference between DSM-III-R and DSM-IV criteria
(Table 8) for schizophrenia is in the description of characteristic symptomatology. The
criterion for duration of acute phase symptoms is extended from one week to one
month. Hallucinations are no longer required to be prominent. DSM-IV uses the term
”disorganized speech” instead of ”incoherence or marked loosening of associations” for
schizophrenic thought disorder. Besides catatonic symptoms, grossly disorganized
behaviour is included as a symptom criterion. Negative symptoms are included in the
criteria for the first time in the DSM system. (APA 1994)
The subtype names are identical to those used in DSM-III-R, but a hierarchy is given
for them. Catatonic type is assigned whenever prominent catatonic symptoms are
present regardless of other symptoms. If the criteria for catatonic type are not fulfilled,
the disorganized type is assigned whenever disorganized speech and behaviour, and flat
or inappropriate affect are present. If the criteria for neither catatonic nor disorganized
type are present, the paranoid type is assigned whenever there is a preoccupation with
delusions or frequent hallucinations. If there are prominent active-phase symptoms and
the criteria for catatonic, disorganized, or paranoid type are not fulfilled, the
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undifferentiated type is assigned. The residual type is used when active-phase
symptoms are no longer present but there is continuing evidence for the disturbance.
(APA 1994)
Table 8. DSM-IV Diagnostic Criteria for schizophrenia
A. Characteristic symptoms: Two or more of the following, each present for a
significant portion of time during a 1-month period (or less if successfully treated):
1. Delusions
2. Hallucinations
3. Disorganized speech
4. Grossly disorganized or catatonic behaviour
5. Negative symptoms
Only one Criterion A symptom is required if delusions are bizarre or hallucinations
consist of a voice keeping up a running commentary on the person’s behaviour or
thoughts, or two or more voices are conversing with each other.
B. Social/occupational dysfunction: for a significant portion of the time since the onset
of the disturbance, one or more major areas of functioning such as work, interpersonal
relations, or self-care are markedly below the level achieved prior to the onset (or, when
the onset is in childhood or adolescence, failure to achieve the expected level).
C. Duration: Continuous signs of the disturbance persist for at least 6 months, of which
at least one month should be of symptoms that meet Criterion A. The 6 months may
include periods of prodromal and residual symptoms.
D. Schizoaffective and mood disorder exclusion: Schizoaffective disorder and mood
disorder with psychotic features have been ruled out because either no major depressive,
manic, or mixed episodes have occurred concurrently with the active-phase symptoms,
or if mood episodes have occurred during active-phase symptoms, their total duration
has been brief relative to the active and residual periods.
E. Substance/general medical condition exclusion: The disturbance is not due to the
direct physiological effects of a substance or a general medical condition.
F. Relationship to a pervasive developmental disorder: if there is a history of autistic
disorder or another pervasive developmental disorder, the additional diagnosis of
schizophrenia is made only if prominent delusions or hallucinations are also present for
at least a month (or less if successfully treated).
(APA 1994)
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2.1.13. Summary of the evolution of the concept of schizophrenia, and concordance
between diagnostic systems
During the 20th century, psychiatric nosology has evolved from ”the great professor
principle” through ”the consensus of experts” to a scientific psychiatric nosology
(Kendler 1990). The diagnostic concepts of schizophrenia of Kraepelin, Bleuler, and
Schneider followed the great professor principle. While the detailed descriptions of
symptoms in schizophrenia given by Kraepelin and Bleuler were quite similar, both
men came to regard totally different aspects of the disorder as essential: while Kraepelin
stressed chronicity and poor outcome, Bleuler stressed the presence of fundamental
symptoms of disordered association, attention, and affectivity, plus autism and
ambivalence (Kraepelin 1919, Bleuler 1911). Both described the hallucinations and
delusions later termed first-rank symptoms by Schneider, but neither regarded them as
essential features of schizophrenia (Kraepelin 1919, Bleuler 1911). Thus, by analogy, in
trying to define the essentials of an elephant, Kraepelin chose ”trunk”, Bleuler ”ears”,
and Schneider ”feet”.
DSM classifications prior to DSM-III, and ICD classifications prior to ICD-10, relied
on the consensus of experts principle. In the 1960s this consensus was quite different in
Europe and the United States. Thus, DSM-II adopted a broad Bleulerian definition of
schizophrenia, while ICD-8 descriptions focused on Schneiderian first-rank symptoms.
When comparisons of diagnostic concepts in the United Kingdom and United States
were conducted in the 1960s and 1970s, it became evident that American psychiatrists
diagnosed schizophrenia much more often than their British counterparts, who were
more likely to diagnose affective disorders (Leff 1977). Psychiatrists in Nordic
countries also applied a narrow definition of schizophrenia (Leff 1977). The large
variation in diagnostic practices promoted the development of scientific nosology in
psychiatry (Kendler 1990). Since Feighner’s criteria, available scientific knowledge has
been used to develop diagnostic criteria. European psychiatrists have trailed behind their
American colleagues in this development, ICD-10 being the first European
classification to provide operational diagnostic criteria.
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Scientific nosology aims at maximizing the reliability and validity of diagnostic
concepts. Criteria are reliable if diagnosticians in different countries reproduce the same
diagnosis from the same patients. The validity of a diagnostic concept is a much more
complex matter. It is usually tested by using external validators, such as family history,
biological and psychological tests, treatment response, diagnostic stability, and course
of illness. However, different validators often fail to agree. For example, DSM-III
criteria for schizophrenia define a patient population with a relatively poor outcome, but
if family history were to be included as a validator, broader criteria for schizophrenia
should be applied. A consensus of experts usually decides which validator should be
given the highest priority, which has led to differences between diagnostic systems.
(Kendler 1990)
The most often used diagnostic criteria in clinical practice and research nowadays are
DSM-IV, ICD-10, RDC, and Feighner criteria. Although the definitions of
schizophrenia in different diagnostic systems converge to a large extent, there are
differences (Table 9). All except Feighner criteria give considerable weight to
Schneider’s first rank symptoms, although DSM-IV less so than RDC and ICD-10. The
required duration of symptoms is variable, ranging from 2 weeks in RDC to 6 months in
DSM -IV and Feighner criteria. The boundaries of schizophrenia, schizoaffective
disorder and psychotic affective disorder are highly variable. Feighner and DSM-IV
criteria follow the Kraepelinian tradition of stressing poor outcome, while such a
criterion has not been included in RDC and ICD-10. The agreements between the
systems in terms of clinical diagnoses are not impressive. In one study, the
concordances for schizophrenia measured by kappa values (Shrout et al 1987) were 0.67
for DSM-III vs. RDC, 0.57 for DSM-III vs. Feighner criteria, and 0.44 for RDC vs.
Feighner criteria (McGorry et al 1992). In another study, they were 0.64 for DSM-III-R
vs. RDC, 0.59 for DSM-III-R vs. ICD-10, 0.58 for DSM-III-R vs. Feighner criteria, and
0.71 for ICD-10 vs. RDC (Hill et al 1996).
The considerable weighting of Schneider’s first rank symptoms in several diagnostic
systems is particularly problematic. Several studies have shown that they are not
pathognomonic for schizophrenia (Carpenter et al 1973, Peralta & Cuesta, 1999).
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Carpenter et al found them in 51% of patients with DSM-II schizophrenia and in 23% of
patients with DSM-II affective psychoses (Carpenter et al 1973). Peralta and Cuesta
found them in 69% of patients with schizophrenia, 83% with schizophreniform disorder,
65% with schizoaffective disorder, 43% with mood disorder, 52% with brief reactive
psychotic disorder, and 48% of patients with psychotic disorder not otherwise specified,
in a study that used DSM-III-R criteria (Peralta & Cuesta 1999). Having first-rank
symptoms did not significantly increase the likelihood of having schizophrenia (Peralta
& Cuesta 1999), and was not associated with duration of illness or its outcome
(Carpenter et al 1973). Thus, first-rank symptoms seem to correlate poorly with all of
the external validators of diagnostic criteria; they should perhaps be given less weight in
future diagnostic criteria of schizophrenia and be considered as symptoms of psychosis
rather than of schizophrenia (Peralta & Cuesta 1999).
Table 9. Comparison of diagnostic criteria for schizophrenia
Diagnostic
system
Duration Course Affective
symptoms
Other requirements Weight
on FRS
DSM-IV >6 months Deterioration
from
premorbid
level of
functioning
Affective
syndrome
included if
relatively brief
Substance/general
medical condition
exclusion
+
RDC >2 weeks - No prominent
affective
symptoms
- ++
ICD-10 >1 month - If present,
must follow
psychotic
symptoms
Substance/general
medical condition
exclusion
++
Washington
University
Criteria
(Feighner
Criteria)
>6 months Chronic
illness without
return to
premorbid
level of
functioning
Absence of
symptoms
qualifying for
affective
disorder
At least 3 of 5:
1. Single
2. Poor premorbid
social or work
adjustment
3. Family history of
schizophrenia
4. No substance abuse
within 1 year of onset
5. Onset before 40
years
-
(Feighner et al 1972, Spitzer et al 1978, WHO 1993, APA 1994, Hill et al 1996)
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However, radical changes in diagnostic criteria always cause problems in research if
results from studies using the new criteria are no longer comparable with previous
findings. Because of the inconvenience relating to major changes in diagnostic criteria,
the DSM-IV Work Group adopted an attitude of "progressive conservatism”: changes
were made only if their advantages clearly outweighed their disadvantages (Andreasen
1994). It would seem likely that this reluctance to change will continue when the DSM
and ICD criteria are next updated.
2.1.14. Diagnostic criteria for schizophrenia in Finland
Finland adopted the ICD-6 diagnostic classification for clinical use in 1954
(Lääkintöhallitus 1953). No separate criteria for schizophrenia were given in the
classification. Schizophrenia was divided into seven subtypes: simple, hebephrenic,
catatonic, paranoid, latent, and not otherwise specified, plus schizoaffective disorder
and acute schizophrenic reaction.
The 1950s and 1960s saw a wealth of schizophrenia research in Finland. The diagnostic
criteria used varied somewhat. The criteria used by Achté and Alanen were based on
Langfeldt’s primary symptoms of schizophrenia (Langfeldt 1969). Achté's criteria
included ten malignant symptoms of schizophrenia: an alteration of character prior to
the onset of illness in a previously healthy person, autism, schizophrenic disturbances in
affectivity, schizophrenic association disorders, massive experiences of derealization,
massive delusions of influence, massive experiences of depersonalization, specific
schizophrenic hallucinations of conversation with voices or physical delusions,
avolition, and catatonic stupor (Achté 1967, p. 317). A patient who clearly exhibited
one or more of these symptoms was regarded as suffering from typical schizophrenia
(Achté 1967, p. 317). The criteria used by Alanen et al were otherwise similar but did
not include character alteration and avolition (Alanen et al 1966).
Between 1969 and 1986, the official diagnostic classification used in Finland was
ICD-8 (Lääkintöhallitus 1968). The subtyping remained identical to ICD-6, and no
diagnostic criteria were provided. However, the diagnostic concept of schizophrenia
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applied by clinicians was assessed in several studies. In a study of first-contact patients
with schizophrenia or schizophreniform disorder in Helsinki in 1975, only 52% of the
patients who received a DSM-III diagnosis of schizophrenia or schizophreniform
disorder had received a hospital discharge diagnosis of schizophrenia or
schizophreniform disorder (Kuusi 1986). In another study of all first admissions to
Helsinki’s two mental hospitals in 1981, 35% of the patients received a diagnosis of
schizophrenia (S+) or borderline psychosis (O+) as assigned by the CATEGO computer
program based on a Present State Examination-interview conducted blind to clinical
diagnoses, but only 19% had received a clinical diagnosis of schizophrenia or
schizophreniform disorder (Pakaslahti 1987). And in an incidence study carried out
between March 1 1983 and February 29 1984 covering six health care districts in
Finland, Salokangas also observed that clinicians made a DSM-III diagnosis of
schizophrenia less often than an independent researcher (Salokangas 1993).Thus, the
diagnostic concept of schizophrenia applied by Finnish clinicians was narrow during the
1970s and 1980s.
In 1987, the general medical diagnostic classification system in Finland was updated to
ICD-9. However, the diagnostic criteria for mental disorders were adopted with slight
modifications from DSM-III-R (Lääkintöhallitus 1989). In this system, the first four
numbers in the diagnostic codes corresponded to the ICD-9 codes, but the fifth digit was
unique to the Finnish coding system and allowed for subclassification similar to that
used in DSM-III-R (Kuoppasalmi et al 1989). The diagnostic criteria for schizophrenic
psychoses were identical to the DSM-III-R criteria, but unlike in DSM-III-R,
schizophreniform and schizoaffective disorders were classified as schizophrenic
psychoses (Kuoppasalmi et al 1989). Studies comparing research and clinical
DSM-III-R diagnoses conducted in the 1990s found a continuing tendency of Finnish
psychiatrists to apply a narrow definition of schizophrenia. Isohanni et al compared
clinical and research diagnoses in the Northern Finland 1966 birth cohort and found 71
patients fulfilling DSM-III-R criteria for schizophrenia, whereas only 37 of them had a
Finnish Hospital Discharge Register diagnosis of schizophrenia (Isohanni et al 1997). In
a sample of patients from one municipality, 87% with a schizophrenia diagnosis and
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18% with a schizophrenia spectrum diagnosis in the register fulfilled DSM-III-R criteria
for schizophrenia (Mäkikyrö et al 1998).
Since 1996, ICD-10 diagnostic codes and criteria have been used in Finland. Thus far,
the effect of this change on clinical practice has not been studied.
2.2. Symptoms of schizophrenia
Schizophrenia is clinically heterogeneous. Its course and symptomatology are highly
variable, which is probably one reason for the variability of results from studies on
treatment, aetiology, and pathophysiology. This heterogeneity has led to a growing
interest in defining specific groups of symptoms or domains of psychopathology which
might be used to identify patients with a more homogenous clinical picture and,
hopefully, a more homogenous aetiological background. (Rotakonda et al 1998)
The first widely used classification into symptom domains was the subdivision into
positive and negative symptoms. These terms were invented by Hughlings-Jackson,
who considered positive psychotic symptoms as an exaggeration of normal functioning,
a release phenomenon caused by an absence of inhibitory or regulatory influences,
while negative symptoms were caused by a simple loss of function. Hallucinations,
delusions, disorganized speech and behaviour, and catatonic symptoms were considered
as positive symptoms, while anhedonia, avolition, poverty of speech and affective
blunting were classified as negative symptoms. (Andreasen 1982, Andreasen 1995)
The positive vs. negative symptom dichotomy achieved widespread use in both research
and clinical work. Various rating scales for their assessment were developed (Andreasen
1982, Fenton and McGlashan 1992, Möller et al 1994). Negative symptoms were shown
to be associated with poor premorbid functioning, insidious onset, intellectual
impairment, and poor outcome, while the relationship between positive symptoms and
outcome was less clear-cut (Crow 1985, Andreasen et al 1990, Fenton and McGlashan
1991). Negative symptoms were also associated with structural brain abnormalities and
neuropsychological deficits (Andreasen et al 1990, Andreasen 1995).
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Various subtypings or classifications related to positive and negative symptoms were
also suggested. Andreasen and Olsen suggested a subtyping of schizophrenia into three
categories - positive, negative, and mixed – based on the prominence of positive or
negative symptoms, or both. They found that compared with the other two groups,
patients with negative schizophrenia had significantly poorer premorbid adjustment, and
poorer work and cognitive functioning. (Andreasen et al 1990, Andreasen & Olsen
1995a)
Crow suggested in 1980 that there are two syndromes in schizophrenia, each reflecting
different psychopathology: Type I caused by increased number of D2 dopamine
receptors, characterised by positive symptoms, good response to neuroleptics, good
outcome, and absence of intellectual impairment, and Type II caused by cell loss in
temporal lobe structures, characterised by negative symptoms, cerebral ventricular
enlargement, poor response to neuroleptic treatment, intellectual impairment, and
abnormal involuntary movements. According to Crow, these subtypes share common
aetiology, but Type I reflects the neurochemical component of schizophrenia, and Type
II the structural component. (Crow 1985)
Carpenter et al (1988) emphasized the distinctions between negative symptoms and
disorders in relating, and between primary and secondary negative symptoms. Disorders
in relating, for example social withdrawal, may be caused by loss of social drive, but
also by paranoid delusions. Thus, they should not be considered as negative symptoms.
Secondary negative symptoms refer to negative symptoms that are caused by drug
effects, depression, or absence of social stimulation, among others. Secondary negative
symptoms should be responsive to changes in the factors with which they are
associated. Primary negative symptoms are less responsive to state changes and are
rarely fully remitting. Carpenter et al suggested that negative symptoms should be used
as a descriptive term without implications concerning cause or duration, whereas
primary negative symptoms, which are present as enduring traits, should be called
”deficit symptoms” . The syndrome associated with deficit symptoms was called ”the
deficit schizophrenia”, and was associated with enduring negative symptoms, poor
outcome, and a significant male excess. (Carpenter et al 1988)
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The classification of symptoms as positive or negative has not always been
straightforward. To solve the problem of classification, researchers applied factor-
analytic techniques and consistently found that the interrelationships among the
symptoms of schizophrenia are better accounted for using three dimensions: positive or
psychotic, negative, and disorganized symptoms (Andreasen et al 1995a). Disorganized
symptoms consist of disorganized speech, inappropriate affect, and bizarre behaviour.
In a longitudinal study of the dimensions, symptoms within the three groups tended to
change in unison, but the symptom groups changed independently from one another
(Arndt et al 1995).
Recent studies have found that disorganized symptoms may be more familial than
positive and negative symptoms: they are moderately correlated within affected sibling
pairs (Cardno et al 1998, Loftus et al 1998), and are associated with an increased risk of
nonaffective psychotic disorders in first-degree relatives (Cardno et al 1997, Van Os et
al 1997). Negative symptoms continue to be associated with poor social outcome and
poor quality of life in recent studies, while positive and disorganized symptoms do not
have similar predictive value (Ho et al 1998). However, in a large follow-up study of
first-episode patients with schizophrenia, only severity of positive symptoms was
associated with treatment response (Robinson et al 1999), and none of the symptom
dimensions was associated with relapse rate (Robinson et al 1999a).
However, the symptom dimensions of positive, negative, and disorganized symptoms
are not unique to schizophrenia, being found in other psychotic disorders as well
(Maziade et al 1995, Johnstone & Frith 1996, Serretti et al 1996, Rotakonda et al 1998).
Moreover, associations between the symptom dimensions and clinical variables (poor
premorbid functioning and negative symptoms, continuous course of illness and
disorganized symptoms) have been found regardless of the diagnosis (Rotakonda et al
1998). It may be that these symptom dimensions or psychopathological domains reflect
discrete pathophysiologic conditions (Rotakonda et al 1998). Consequently, it has been
suggested that future aetiological research might benefit by including symptom
dimensions in identifying groups to be studied (Serretti et al 1996).
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2.3. Epidemiology of schizophrenia
2.3.1. Occurrence of schizophrenia
There are two types of measures of occurrence: rates and proportions. A proportion is
dimensionless but rate is not, because time is retained in the unit of measurement. The
most common rate-type of measure of occurrence is incidence rate or incidence density.
Incidence rate quantifies the number of events occurring per unit of population per unit
of time, usually the number of new cases occurring in one year per 1000 or 100 000
person years. The two most commonly used proportion-type measures of occurrence are
cumulative incidence and prevalence. Cumulative incidence is calculated as the number
of health outcomes occurring over a time interval divided by the size of the population
at risk. Cumulative incidence is a suitable measure of occurrence in cohort studies
where the loss to follow-up over the course of the study is negligible. Prevalence is the
proportion of a population who have a particular health condition at a point or period
(one year, lifetime) in time. The prevalence of schizophrenia is determined as the total
number of cases now alive, presently or previously actively psychotic, divided by the
size of the population. (Zahner et al 1995, pp. 24-25, Gottesman & Shields 1982, p. 19)
A proportion-type morbidity index commonly used in population and genetic studies is
lifetime morbid risk (MR) or lifetime risk. The lifetime morbid risk is the probability
that a person who survives through the period of susceptibility of manifestation will
develop the disorder. If n is the total number of subjects and m is the total number of
affected, the raw total rate would simply be m/n, but this would underestimate the
morbidity risk since some of the well subjects who have not yet lived through the period
of susceptibility may still develop the disorder. To adjust for the age of the observed
sample, an age-corrected denominator called Bezugsziffern (BZ) is calculated. BZ is the
sum of weights reflecting each subject’s length of exposure to risk up to the age of
examination. If wi is the weight for the ith individual, MR is estimated by
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(Faraone & Tsuang 1995, p. 115)
2.3.1.1. Prevalence
There is still a widely held view that the prevalence of schizophrenia is approximately
1% throughout the world (Schultz & Andreasen 1999). However, in a review of all
prevalence studies conducted thus far, Torrey found a prevalence range exceeding 50-
fold from the lowest (0.3 per 1000) to the highest (17 per 1000) reported (Torrey 1987).
As he pointed out, all aetiological hypothesis, whether genetic, environmental or both,
would predict significant differences in the prevalence of the disease; it would actually
be surprising if no differences were found (Torrey 1987).
Recent studies using structured interviews and DSM-III-R criteria for schizophrenia
have found prevalences that are considerably lower than the usually cited 1%. The
National Comorbidity Survey, which was based on interviews of 8098 individuals
representing a random sample of the United States population, found a 0.7% lifetime
prevalence of all nonaffective psychotic disorders and a 0.15% lifetime prevalence of
schizophrenia (Kendler et al, 1996). The lifetime prevalence of schizophrenia in the
Irish Roscommon study was 0.54% in men and 0.26% in women (Kendler & Walsh
1995). In the British Hampstead Schizophrenia Survey, the point prevalence of
DSM-III-R schizophrenia varied, depending on the age correction method used,
between 0.3 and 0.48% (Jeffreys et al 1997).
In Finland, the lifetime prevalence of schizophrenia seems to be somewhat higher than
elsewhere: 1.3% in the Mini-Finland Health Survey, which used the Present State
Examination interview (Lehtinen et al 1990), and 1.2% in a register-based study
(Hovatta et al 1997). In the UKKI (Uusikaupunki - Kemijärvi) study, the lifetime
prevalence of all nonaffective psychotic disorders as defined by the Present State
Examination was 2.7% in the population aged 30-80 years (Lehtinen et al 1990a).
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However, these studies were based on diagnostic criteria that are broader than the
DSM-III-R criteria.
2.3.1.2. Incidence
Prevalence of a disease in a population is proportional to the frequency of development
of new cases only if the numbers of entries to and exits from the population are stable
(Zahner et al 1995, p.26). These are dependent on birth and death rates and migration,
which are rarely stable. Differences in prevalences between different countries may thus
be caused by differences in migration patterns and population age structures. Therefore,
incidence rates are epidemiologically more informative than prevalence (Campbell &
Machin 1993, p. 117). In schizophrenia research, the use of incidence rates is preferable
also because of the excess mortality among patients with schizophrenia (Brown 1997)
which tends to decrease the observed prevalences.
The World Health Organization Ten Country Study has been the most systematic
attempt to compare the epidemiology of schizophrenia in different countries and
cultures using uniform evaluation and diagnostic criteria. The diagnostic assessment
was conducted using the Present State Examination interview, and diagnoses were
obtained using the CATEGO computer program. The incidence of narrowly defined
schizophrenia in the ten populations aged 15-54 years varied between 0.7 and 1.4 per
10 000 person years. The differences were not statistically significant. However, the
incidence of broadly defined schizophrenia varied significantly, between 1.6 and 4.2 per
10 000 person years. These findings were interpreted to suggest that the incidence of
schizophrenia is similar worldwide. (Jablensky et al 1992)
Three recent studies, conducted in the Caribbean islands, applied the same methodology
as the WHO Ten Country Study (Hickling et al 1995, Bhurga et al 1996, Mahy et al
1999). All found a slightly higher incidence of narrowly defined schizophrenia; 1.6 per
10 000 person years in Trinidad, 2.1 per 10 000 person years in Jamaica, and 2.8 per
10 000 person years in Barbados, while the incidence of broadly defined schizophrenia
was within the limits of those observed in the WHO study (2.2, 2.4, and 3.2 per 10 000
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person years, respectively) (Bhurga et al 1996, Hickling et al 1995, Mahy et al 1999).
However, the incidence of schizophrenia among African-Caribbean migrants in Europe
has been found to be considerably higher. In Nottingham, the incidence of ICD-10
schizophrenia was 15 per 10 000 person years among first or second generation
African-Caribbean migrants when, at the same time, it was 1.7 per 10 000 person years
in the rest of the host population (Harrison et al 1997). Considerably increased
incidences of schizophrenia among the African-Caribbean population have also been
observed in other parts of England (Castle et al 1991, Bhurga et al 1997). In The
Netherlands, the risk of developing schizophrenia is approximately 4 times higher
among Surinamese and Dutch Antillean immigrants than in the rest of the population
(Selten et al 1997). Part of the observed increase may be caused by problems in defining
the population at risk in the calculations, because not all immigrants permanently
residing in a country are registered in censuses (Harrison et al 1997), and some of the
hospitalized ”immigrants” may actually be transient visitors (Mortensen et al 1997).
Nevertheless, the observed increase is far too large to be solely explained by such
confounding factors (Harrison et al 1997).
In Finland, the incidence of DSM-III schizophrenia and schizophreniform disorder
among the 15-45-year-olds was 3.6 per 10 000 person years, and the incidence of ICD-8
schizophrenia among the 15-59-year-olds 2.1 per 10 000 person years in an incidence
study carried out between March 1 1983 and February 29 1984 in six health care
districts. Both are higher than the incidence of narrowly defined schizophrenia in the
WHO study but within the range of the incidence of broadly defined schizophrenia
(Salokangas 1993). In Helsinki, the incidence of DSM-III schizophrenia and
schizophreniform disorder in 1975 was 1.9 per 10 000 person years (Kuusi 1986). The
definition of schizophrenia in DSM-III is almost as restrictive as the narrow
schizophrenia assigned by the CATEGO program, but the rates are not comparable
because the age range was 15-54 years in the WHO study and 15-45 in the Finnish
studies. In the UKKI (Uusikaupunki - Kemijärvi) study, the incidence of all psychotic
disorders was 18 per 10 000 person years, but this includes, besides schizophrenia, all
other psychotic disorders and severe personality disorders (Lehtinen et al 1996). A
recent study based on the Finnish Hospital Discharge Register found that the incidence
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of DSM-III-R nonaffective psychotic disorders was 0.74 per 1000 person years in 1990
and 0.69 per 1000 person years in 1993 (Korkeila et al 1998).
2.3.1.3. Changes in the occurrence of schizophrenia
In the 19th century, the numbers of registered ”insane” increased rapidly in England,
Scotland, Ireland, France, and the United States. Numerous mental hospitals had to be
built, and the numbers of first admissions rose throughout the latter part of the century
and until World War I. The reasons for the phenomenon were disputed. Some thought
that it was merely caused by more accurate registration, by changes in legislation that
made it profitable for communities to send their mentally ill residents to mental
hospitals, and by reduced mortality and increased length of stay in mental hospitals.
Others insisted that despite the obvious contribution of these ”nosocomial” factors, a
true increase in the occurrence of insanity, particularly its more severe forms, had
occurred. Edward Hare believed that it had partly been caused by a true increase in
occurrence, because the rise had persisted far longer than the establishment of
registration systems, it was extremely pronounced, and it had continued despite no
changes in mortality in the mental hospitals. He suggested that the incidence of
schizophrenia in particular had increased, because few descriptions of a disease
resembling schizophrenia existed before the 19th century, and in the 18th century it was
thought that young people were rarely liable to insanity. A rapid increase in the
incidence of schizophrenia would also explain the rather abrupt development of interest
in schizophrenia particularly during the latter part of the 19th century - although the
identification of the two most important organic psychoses at that time, Korsakoff's
psychosis caused by chronic alcoholism and general paresis caused by tertiary syphilis,
may also have increased the interest in functional psychoses (Colp 1995). (Hare 1983,
Hare 1988)
Recent research suggests that the incidence of schizophrenia may be declining. Falls in
incidence (Brewin et al 1997, Balestrieri el al 1998), morbid risk (Waddington &
Youssef 1994, Strömgren 1987) and first-admission rate (Munk-Jørgensen 1987, Munk-
Jørgensen & Mortensen 1992, Joyce 1987, Parker et al 1985, Eagles et al 1988, Geddes
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et al 1993, Takei et al 1996, Der et al 1990, de Alarcon et al 1990) have been reported
from Denmark (Strömgren 1987, Munk-Jørgensen 1987, Munk-Jørgensen & Mortensen
1992), New Zealand (Joyce et al 1987), Australia (Parker et al 1985), Scotland (Eagles
et al 1988, Geddes et al 1993, Takei et al 1996), England (Brewin et al 1997, Der et al
1990, de Alarcon et al 1990), Italy (Balestrieri et al 1998) and Ireland (Waddington &
Youssef 1994). However, the first-admission rate has not decreased in Croatia
(Folnegović 1990), in the Netherlands (Oldehinkel & Giel 1995) and parts of England
(Harrison et al 1991, Castle et al 1991). These findings have prompted debate about
whether the observed decline has been due to genuine changes in the incidence or to
confounding factors such as changes in diagnostic criteria, treatment practice, or
registration (Torrey 1989, Geddes et al 1993, Kendell et al 1993, Harrison & Mason
1993, Munk-Jørgensen 1995).
The reliability of studies that use register-based first-admission rates has been
questioned, because the proportion of patients with schizophrenia who receive the
diagnosis in their first admission compared with later admissions may change (Kendell
et al 1993). This was controlled for in the study by Munk-Jørgensen and Mortensen,
who found a significant decline in the incidence of schizophrenia in Denmark regardless
of the definition of first admission used (Munk-Jørgensen & Mortensen 1992).
However, Kendell et al found that misrecordings of readmissions as first admissions
were common and accounted for a significant proportion of the observed decline in the
incidence in Edinburgh (Kendell et al 1993). The proportion of patients treated
exclusively as outpatients may also have changed, although Kendell et al found no
significant increase in such patients (Kendell et al 1993), and studies including
outpatients (Munk-Jørgensen & Mortensen 1992, Eagles et al 1988) have also detected
a declining incidence.
Diagnostic criteria change. The narrowing clinical concept of schizophrenia, especially
among young male patients, accounted for half of the decline in the study by Kendell et
al (Kendell et al 1993). The decrease in the frequency of discharge diagnosis of
schizophrenia in the United States has been explained as a result of the introduction of
DSM-III (Loranger 1990, Stoll et al 1993). However, considerable variability in
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diagnostic practice between countries used to exist (Leff 1977). Psychiatrists in Nordic
countries, for example, have traditionally applied narrow diagnostic criteria of
schizophrenia in their clinical practice (Pakaslahti 1987, Isohanni et al 1997, Löffler et
al 1994).
Because of the methodological shortcomings of studies (Kendell et al 1993) and –
perhaps – also because of the fixed belief that the incidence of schizophrenia is constant
across countries and time periods (Torrey 1989), some believe that no true change in the
incidence of schizophrenia has occurred, while others are convinced that it is declining
(Geddes et al 1993, Kendell et al 1993, Harrison & Mason 1993, Munk-Jørgensen 1995,
Crow 1995, Crow 1995a). The decline, if genuine, suggests that the frequency or
intensity of risk factors of schizophrenia in the population is decreasing – or that the
frequency or intensity of protective factors is increasing.
In Finland, a decline in the incidence of schizophrenia in the southern, relatively
urbanized province of Uusimaa was already observed in the 1950s (Syvänne 1952):
between 1929 and 1950, the incidence decreased from 0.97 to 0.47 per 1000 person
years. In Helsinki, the incidence declined from 0.85 to 0.43 per 1000 person years
between 1950 and 1965 (Niskanen & Achté 1972), and in Turku from 0.49 per 1000
person years in 1949-1950 to 0.40 per 1000 person years in 1969-1970 (Salokangas
1979). A recent study based on the Finnish Hospital Discharge Register found that the
first admission rate of all DSM-III-R nonaffective psychotic disorders declined from
0.74 per 1000 person years in 1990 to 0.69 per 1000 person years in 1993 (Korkeila et
al 1998). However, in this study the first-ever hospitalisation for psychotic disorder was
defined as having no such hospitalisations during the three years preceding the index
admission (Korkeila et al 1998).
2.3.1.4. Geographical variation in the occurrence of schizophrenia
Studies indicate large differences in the prevalence of schizophrenia between different
countries, and smaller but significant differences in the incidence (Torrey 1987, Torrey
1989). In addition, pockets of very high and very low prevalence have been detected
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(Torrey 1987). The lowest reported prevalence (0.3 per 1000, age-corrected 0.5 per
1000) has been reported among the Amish population of the United States (Torrey
1987), and the highest in a community in northern Finland (22 per 1000, age-corrected
lifetime risk 3.2%) (Hovatta et al 1997). Also significant within-country variations in
prevalence (Lehtinen et al 1990, Torrey & Bowler 1990, Youssef et al 1991, Hovatta et
al 1997) and morbid risk (Youssef et al 1993, Hovatta et al 1997) have been observed.
The most striking differences in the occurrence of schizophrenia within countries relate
to urban-rural differences. The prevalence of schizophrenia has been repeatedly
observed to be higher in urban than rural areas, but previously this was assumed to be
caused by social drift – patients with schizophrenia ”drift” into urban areas as a
consequence of their illness or its prodromal symptoms (Freeman 1994, Torrey &
Bowler 1990). However, Lewis et al showed in a Swedish conscript cohort that urban
upbringing, not urban residence, was associated with increased risk of developing
schizophrenia in adulthood (Lewis et al 1992). The odds ratio was highest among those
who had grown up in cities (Stockholm, Göteborg, Malmö) (Lewis et al 1992). Since
then, several studies have found an increased risk of schizophrenia among the urban-
born, particularly those born in cities (Takei et al 1995, Marcelis et al 1998, Mortensen
et al 1999). A relationship between urban birth and environmental risk factors operating
prenatally or early in life has been suggested (Freeman 1994, Takei et al 1995,
O’Callaghan et al 1995).
Significant geographical differences in the occurrence of schizophrenia have also been
observed in Finland, but here the occurrence of schizophrenia is lower in urban areas.
This was already observed in the 1960s. The rates of new disability pensions granted
because of schizophrenia and other psychotic disorders were highest in eastern and
lowest in southwestern Finland, and within each of the studied regions the rates were
higher among those living in rural areas (Suominen 1975). In a more recent study of
first-contact psychiatric patients, the incidence of all psychotic disorders among the
population over 15 years varied between 0.80 per 1000 in Helsinki and 1.61 in the north
Karelia (Salokangas et al 1987). The prevalence of schizophrenia in the Mini Finland
Health Survey varied between 0.9% in the urbanized southern and southwestern Finland
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and 2.1% in northern Finland (Lehtinen et al 1990), and even larger differences in
prevalence were observed in a register-based study (Hovatta et al 1997). The most
recent study, based on hospital treatments in 1993-1994, found that the first-admission
rate of nonaffective psychotic disorders per 1000 person years varied between 0.56 in
southwestern and 0.84 in eastern Finland, while the first-admission rate of affective
disorders varied between 0.51 in northern and 0.84 in eastern Finland (Korkeila et al
1998). Thus, the incidence of psychotic disorders seems to have been higher in rural
areas for decades, and this applies also to affective disorders, particularly in eastern
Finland (Suominen 1975, Korkeila et al 1998a).
2.3.2. Age at onset of schizophrenia
The age at onset of schizophrenia is usually defined as the age at the onset of first
psychotic symptoms (interview-based studies) or at the beginning of first hospitalization
for schizophrenia (register-based studies). The age at the onset of prodromal non-
psychotic symptoms has also been used in some studies. Although the age at onset may
vary by several years depending on the definition used (Maurer & Häfner 1995), the
times of onset of behavioural change, positive symptoms, and first hospitalization are
usually correlated within individuals (DeLisi 1992).
The peak age at onset of schizophrenia occurs in early adulthood (Kraepelin 1919 p.
224, Bleuler 1911 p. 341, Sham et al 1994, Castle et al 1995). Females tend to have a
later age at onset than males (Castle et al 1995) and a different age at onset distribution:
that among males shows a single marked peak in the early twenties, while the
distribution among females is bimodal with a second peak in the 45-54-year age group
(Castle et al 1995, Sham et al 1994).
The sex difference in the age at onset has not been found in all studies (Folnegović et al
1990, Kendler & Walsh 1995), and this is notably the case in many Finnish studies
(Kuusi 1986, Salokangas 1993, Hovatta et al 1997). Recent research suggests that the
later age at onset in females may be confined to patients without a family history of
schizophrenia, since no sex differences in the age at onset exist among patients with a
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positive family history for schizophrenia (Shimizu & Kurachi 1989, Albus et al 1994,
DeLisi et al 1994, Murphy et al 1994, Albus et al 1995, Gorwood et al 1995).
The ages of onset of affected siblings are correlated. The correlation coefficient for the
onset ages in pairs of affected siblings has varied between 0.24 and 0.26 (DeLisi et al
1987, Kendler et al 1987, Burke et al 1996, Cardno et al 1998). A positive family
history of schizophrenia is associated with an earlier age at onset (Kendler & MacLean
1990a, Maier et al 1993, Sham et al 1994, Albus et al 1994, Alda et al 1996). Early age
at onset also predicts a higher risk of rehospitalization (Eaton et al 1992), poor outcome
(Loebel et al 1992), and neuroleptic resistance (Meltzer et al 1997).
A family study of patients with schizophrenia (61%), delusional disorder (31%) or
schizoaffective disorder (8%) with onset after the age of 60 found no increased risk of
schizophrenia in the relatives of such patients, whereas the risk of major depression was
significantly higher among relatives of patients than in those of matched controls
(Howard et al 1997). Because of possible aetiologic heterogeneity, the authors suggest
that at least a coding for late age at onset should be included in subsequent revisions of
DSM and ICD (Howard & Rabins 1997).
2.3.3. Sex differences in schizophrenia
The question of whether schizophrenia is more common among males is controversial.
Already in Kraepelin's material, males (57%) outnumbered females (43%) (Kraepelin
1919, p. 231). Some recent studies have replicated this observation (Kendler & Walsh
1995, Hovatta et al 1997), although the findings were mixed in the WHO Ten Country
Study: males tended to have a higher incidence in the European centres, while
elsewhere the disparity was often reversed (Jablensky et al 1992). The difference in the
incidence or prevalence of schizophrenia between males and females diminishes or
disappears when broader diagnostic criteria are applied and when other nonaffective
psychotic disorders are included in the definition (Castle et al 1993, Goldstein 1997).
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Besides a lower incidence and later age at onset, females tend to show better premorbid
functioning, better social functioning, and a more benign course of illness (Salokangas
1983, Castle et al 1995, Goldstein 1997). Males have more negative symptoms and
females more positive and affective symptoms (Castle et al 1994, Goldstein 1997).
Males also have more structural brain abnormalities than females (Goldstein 1997).
The difference in the outcomes tends to diminish with advancing age (Goldstein 1997,
Childers & Harding 1990). This, and the presence of a bimodal age-at-onset distribution
among females, has been suggested to result from a protective effect of estrogen in
females (Castle et al 1995, Goldstein 1997, Häfner et al 1998). In animal studies,
estrogen has had effects on the dopaminergic, noradrenergic, serotonergic, and GABA
(gamma-aminobutyric acid)-ergic systems (Castle et al 1995, Häfner et al 1998).
However, direct evidence for this estrogen hypothesis is scarce; for example, no
connection between the onset of schizophrenia and recent menopause has been observed
(Castle et al 1995).
Although females seem to be somewhat less prone to schizophrenia and, when they do
develop it, are more likely to have a benign course of the disorder, female sufferers with
schizophrenia seem to have more risk factors for schizophrenia (Castle et al 1995).
Several family studies have observed that the relatives of female patients show a higher
morbid risk of schizophrenia and schizophrenia spectrum psychotic disorders than
relatives of male patients (Castle et al 1995, Goldstein 1997), although others have
failed to replicate this finding (Kendler & Walsh 1995). Some studies have reported that
the increased risk of schizophrenia after second-trimester exposure to an influenza
epidemic is confined to females (O'Callaghan et al 1991, Takei et al 1994). Castle and
Murray have suggested that the reason for the sex differences in the incidence,
symptoms, clinical course, and risk factors might be that there are subtypes of
schizophrenia to which males and females are differently susceptible (Castle et al 1994,
Castle et al 1995).
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2.3.4. Seasonal variation of births in schizophrenia
Schizophrenic patients worldwide have a 5-8% excess of births during the winter and
spring months compared with the general population (Torrey et al 1997). The peak
months of schizophrenic births have been between January and April in the Northern
hemisphere, and between July and September in the Southern Hemisphere. However,
the winter-spring excess is smaller and less consistent in the Southern Hemisphere
(McGrath & Welham 1999). Within countries, the seasonal variation in some studies
has been more pronounced among the urban-born than the rural-born (O’Callaghan et al
1995), while others have not detected such an association (Mortensen et al 1999).
Studies of sex differences have given contradictory results, some finding more
pronounced seasonality among females, others among males. Shifts in the peak of
seasonal variation over time have also been observed. (Torrey et al 1997)
The cause of the seasonal variation of births in schizophrenia is unknown. A statistical
artifact caused by age incidence has been suggested (Lewis 1989), and refuted (Dalén
1990, Pulver et al 1990, Torrey & Bowler 1990a, Watson 1990). It has also been
suggested that parents of patients with schizophrenia have a seasonal conception pattern
that is slightly different from that of the general population. This so-called procreational
habits hypothesis predicts that siblings of patients should also have a winter-spring
excess in their births. This has not been supported by studies conducted on the siblings
of patients with schizophrenia, but the sample sizes have been relatively small. (Torrey
et al 1997)
Several theories have linked seasonality of births to genetic factors, pregnancy and birth
complications, nutritional deficiencies, weather effects, and to seasonal variation in
light, external toxins, or hormonal levels. Studies that have investigated the association
between pregnancy and birth complications and seasonal variation of births have
obtained contradictory results, some finding more complications among the winter-
born, others among the summer-born (Torrey et al 1997). However, sample sizes have
been small. Several researchers have suggested that the winter-spring excess of births in
schizophrenia may be caused by variations in maternal hormonal levels brought about
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by seasonal variations in light (Torrey et al 1997). The hypothesis is indirectly
supported by findings of a latitude gradient in the magnitude of the seasonal variation
(Torrey et al 1977). Hypotheses that link seasonal variation of births in schizophrenia to
nutritional deficiencies and exposures to industrial chemicals have not been tested
(Torrey et al 1997).
Several studies have investigated the association between outdoor temperature during
gestation and seasonal variation of births. Asssociations between both exceptionally
high and low temperatures during gestation and the magnitude of the seasonal variation
have been reported, but several studies have also failed to detect any association
between seasonal variation of births in schizophrenia and outdoor temperature (Torrey
et al 1997). Somewhat more encouraging results have been obtained from studies
searching for associations between infectious epidemics during gestation and
seasonality of births in schizophrenia. However, these findings have concerned a variety
of infections (Watson et al 1984, Torrey et al 1988, Takei et al 1996, Torrey et al 1997).
2.4. Genetic epidemiology of schizophrenia
Classic epidemiology was interested in finding environmental risk factors for diseases,
while classic genetics focused on finding genes causing or predisposing to illnesses.
Genetic epidemiology is interested in both genetic and environmental causes of
diseases. The basic terminology of genetic epidemiology is presented in Table 10.
(Faraone & Tsuang 1995, p. 81)
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Table 10. Basic terminology of genetic epidemiology
Concept Significance
Allele A different form of the same gene
Anticipation Exacerbation in the disease (earlier onset and/or more severe form) from
parent to child
Association studies Assess the association of a disease and genetic markers in unrelated patients
and controls
Autosome Non-sex chromosome
Concordance Proportion of twin pairs who are similarly affected
Dominant allele An allele that is expressed if either of the pairs of a chromosome has it
Gene-environment
interaction
Different effect of a genotype on disease risk in persons with different
environmental exposures
Genetic
heterogeneity
Different genes cause the same disorder
Genetic marker A DNA sequence with a known chromosomal location
Genotype Genetic constitution
Haplotype A group of closely located alleles which are inherited together as a unit
Heritability Measures the degree to which genetic factors influence variability in the
phenotype: if phenotypic variability (Vp) is divided into statistically
independent genetic (Vg) and environmental variability (Vc), heritability (h2)
can be calculated as the ratio of genetic and phenotypic variances (h2= Vg/ Vp).
Specific to the population and time period studied.
Heterozygosity Different alleles are present at a given locus on the pairs of a chromosome
Homozygosity The same allele is present at a given locus on both pairs of a chromosome
Incomplete
penetrance
All individuals possessing a disease gene do not manifest the disease
Liability Predisposition to develop a disorder
Linkage Close proximity of loci on a chromosome
Linkage analysis Assesses the association of disease and a genetic marker within families
Locus The site of a specific gene on a chromosome
Lod score Logarithm of the odds, a statistical term that incidates whether two loci are
linked. A lod score of 3 or higher is commonly accepted as showing linkage.
Pairwise
concordance
Method of calculating concordance in which every pair of twins is counted
only once
Penetrance Frequency with which a particular genotype is expressed by the individuals
possessing it
Phenocopy Case of a particular disease caused entirely by environmental factors
Phenotype The observable characteristics of an individual, determined by genetic and
environmental factors
Proband Name used for cases and controls in genetic studies
Pleiotropy Same gene may express more than one phenotype
Probandwise
concordance
Method of calculating concordance in which twin pairs in which both members
are ascertained indepently are counted twice. Only probandwise rates can be
compared directly with the general population occurrence estimates.
Recessive allele An allele that is expressed only if both pairs of a chromosome have it
Vulnerability
indicator
Any genetic, biological, psychological, or behavioural trait that may reflect
liability to develop a disorder
(Gottesman & Shields 1982, Kremen et al 1992, Kendler & Diehl 1993, Faraone & Tsuang 1995, Ottman 1996,
Owen & Craddock 1996, Plomin et al 1997, Skuse 1997, Pekkarinen 1998)
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Faraone and Tsuang have introduced the term ”chain of genetic epidemiologic research”
to describe the logical progression of questions in genetic epidemiologic research. The
first question, ”Is the disorder familial”, is answered using a research design known as
the family study method. The best designs for answering the second question, ”What are
the relative contributions of genes and environment”, are twin and adoption studies. The
answer to the third question, ”What is the mode of transmission”, may be found using
segregation analysis. The answer to the fourth question, ”Where is the gene(s) located”,
is, with luck, found with linkage or association studies. (Faraone & Tsuang 1995, p. 82)
Table 11. Morbid risk of schizophrenia in relatives of probands with schizophrenia
Relationship Morbid Risk Relationship Morbid Risk
General population 1 % Uncles / aunts 2 %
Parents 6 % Nephews / nieces 4 %
Siblings 9 % Grandchildren 5 %
Children 13 % Half-siblings 6 %
Dizygotic twins 17 % First cousins 2 %
Monozygotic twins 48 % Spouses of patients 2 %
(Gottesman 1994)
2.4.1. Is schizophrenia familial? Family studies
Numerous family studies conducted between 1920 and 1987 have confirmed that
relatives of probands with schizophrenia have an increased risk of developing
schizophrenia. The risk decreases rapidly from close to more distant relatives (Table 11)
(Gottesman 1994). First-degree relatives of schizophrenia probands have an
approximately ten-fold risk of developing schizophrenia compared to relatives of
control probands (Kendler & Diehl 1993). The relatives of probands with schizophrenia
also have an increased risk of other disorders known as the schizophrenia spectrum
disorders: schizotypal and paranoid personality disorder, and other nonaffective
psychotic disorders (Kendler & Diehl 1993).
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The results of the most recent epidemiologic family study, the Irish Roscommon Family
Study, are of special interest because of the use of the most sophisticated methodology
and systematic case ascertainment of all the family studies conducted thus far. The
study included three proband groups: schizophrenic, affective, and control. Probands
and all available first-degree relatives were interviewed and rediagnosed according to
DSM-III-R diagnostic criteria. For the deceased and those who could not be traced or
refused to be interviewed, the diagnosis was based on case note information and family
history interview. After diagnostic evaluation, probands were classified into 7 groups:
schizophrenia, schizoaffective disorder, schizotypal personality disorder, other
nonaffective psychosis, psychotic affective illness, nonpsychotic affective illness, and
controls. (Kendler et al 1993a)
The morbid risks of schizophrenia and schizophrenia spectrum disorders and affective
illnesses are presented in Table 12. The numbers are based on morbid risks among
relatives who were personally interviewed. The study confirmed the higher risk of
schizophrenia among relatives of probands with schizophrenia, schizoaffective disorder,
schizotypal personality disorder and other nonaffective psychosis, compared with
relatives of controls. The risk of schizophrenia was also higher among relatives of
probands with psychotic affective illness. Among relatives, the risk of schizophrenia
was significantly higher in siblings than in parents. (Kendler et al 1993a)
The morbid risk of schizoaffective disorder was, compared with relatives of controls,
significantly higher only among relatives of probands with psychotic affective illness.
When schizoaffective disorder and other nonaffective psychosis were merged into a
single diagnostic group, the relatives of probands from all groups except nonpsychotic
affective illness had a significantly higher risk of these combined nonaffective psychotic
disorders than relatives of controls. (Kendler et al 1993b)
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The morbid risk of schizotypal or paranoid personality disorder was significantly higher
among relatives of probands with schizophrenia and schizoaffective disorder, and
almost significantly higher among relatives of probands with schizotypal personality
disorder, other nonaffective psychotic disorder, and nonpsychotic affective disorder
than among relatives of controls. In the relatives of schizophrenic, schizoaffective, and
schizotypal probands, the prevalence of schizotypal or paranoid personality disorder
was more than twice as large in parents as in siblings. (Kendler et al 1993c)
Table 12. Morbid risks of schizophrenia, schizophrenia spectrum disorders,
and affective illnesses among first-degree relatives of probands with 
schizophrenia, schizophrenia spectrum disorder, or affective illness
in the Roscommon Family Study
Proband's Relatives' Morbid Risk
DSM-III-R Schizo- SAD ONAP SPD+ AI BAI
Diagnosis phrenia PPD
Schizophrenia 6.5 2.3 1.2 8.2 24.9 1.2
SAD 6.7 1.8 2.3 5.6 49.7 4.8
SPD 6.9 3.9 5.5 5.0 10.7 0
ONAP 5.1 0 2.1 3.9 26.6 2.2
PAI 2.8 5.8 2.3 3.6 28.8 8.6
NPAI 0.6 2.5 0.6 2.9 31.1 6.6
Control 0.5 0.7 0.7 1.7 22.8 1.4
SAD = schizoaffective disorder
SPD = schizotypal personality disorder
ONAP = other nonaffective psychosis
PAI = psychotic affective illness
NPAI = nonpsychotic affective illness
PPD = paranoid personality disorder
AI = all affective illnesses
BAI = bipolar affective illness
(Kendler et al 1993a-d)
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The morbid risk of all affective illnesses was significantly higher only among relatives
of probands with schizoaffective illness compared with relatives of controls. The risk of
bipolar affective illness was significantly higher among relatives of probands with
psychotic affective illness and almost significantly higher among relatives of probands
with schizoaffective illness than among relatives of controls. However, a substantially
higher proportion of affectively ill relatives of schizophrenic vs. control probands had
psychotic, especially mood-incongruent psychotic, symptoms. (Kendler et al 1993d)
The findings from another large family study using modern diagnostic criteria are
mainly consistent with the Roscommon findings, but some differences emerged. The
Iowa Study was a follow-up and family study of 510 consecutive cases with a discharge
diagnosis of schizophrenia admitted to the Iowa Psychopathic Hospitals from 1934 to
1944, which used structured interviews and DSM-III diagnostic criteria (Kendler et al
1985). As with the Roscommon Study findings, the risk of schizophrenia was increased
not only among relatives of probands with schizophrenia or a schizophrenic spectrum
disorder but also among those of probands with psychotic affective illness (Kendler et al
1985, Kendler et al 1986). Another family study also found an increased morbid risk of
schizophrenia in the relatives of probands with major depressive disorder with mood-
incongruent psychotic features, although this was not statistically significant due to the
small sample size (Maj et al 1991). The relatives of probands with schizoaffective
disorder had as a high risk of schizophrenia as relatives of probands with schizophrenia,
but only the risk of bipolar affective illness was higher among relatives of probands
with schizoaffective disorder than among relatives of controls, while the risk of unipolar
affective disorder was similar to that in the relatives of controls in the Iowa Study
(Kendler et al 1986). In the smaller family study, the risk for major affective disorders
was not increased in the relatives of probands with DSM-III-R schizoaffective disorder,
depressive type (Maj et al 1991).
Family studies have thus consistently shown that schizophrenia is familial, a
predisposition that is not limited to schizophrenia, but to a spectrum of related disorders.
This so-called schizophrenia spectrum includes schizoaffective disorder,
schizophreniform disorder, schizotypal personality disorder, paranoid personality
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disorder, and delusional disorder. The findings of increased risk of schizophrenia among
relatives of probands with psychotic affective illness and the frequent occurrence of
psychotic symptoms among affectively ill relatives of schizophrenic probands certainly
present a challenge to the decision about which disorders to include in the schizophrenia
spectrum, and also to the delineation of the diagnostic boundaries of schizophrenia,
schizoaffective disorder, and psychotic affective illness.
2.4.2. What are the relative contributions of genes and environment?
2.4.2.1. Twin studies
Twin studies offer a powerful method of disentangling the effects of genetic and
environmental factors. Monozygotic twins have almost identical genomes, while
dizygotic twins share only approximately half of their genes. Both usually share the
same rearing environment. Thus, if environmental factors entirely explain the familial
clustering, there should be no differences in the concordances between monozygotic and
dizygotic twins. Conversely, if genetic factors are important, the concordance should be
considerably higher among monozygotic than dizygotic twins. If genetic factors alone
were sufficient determinants, there should be a 100% concordance among monozygotic
twins. The comparison of discordant monozygotic twins helps to identify environmental
factors predisposing to or protecting from schizophrenia. Also, the variability of
abnormality in monozygotic twins helps to identify less severe variants of the same
underlying vulnerability. (Gottesman & Shields, pp. 72-73)
Twin studies have shown that the heritability of schizophrenia in different populations
is high (Kendler & Diehl 1993, Cannon et al 1998, Cardno et al 1999). In a Finnish
national twin cohort, the heritability of schizophrenia was 83%; the remaining 17% of
the variance in liability was due to unique environmental factors, while common
environmental factors seemed to have no influence on the liability (Cannon et al 1998).
The probandwise concordance was 46% among monozygotic twins, and 9% among
dizygotic twins (Cannon et al 1998). The results from a British study were almost
identical: the heritability was 83%, the rest of the liability being best explained by
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unique environmental factors (Cardno et al 1999). The concordance was 41% among
monozygotic and 5% among dizygotic twins (Cardno et al 1999).
The importance of genetic factors also emerged in two studies that investigated the risk
of schizophrenia and schizophrenia spectrum disorders among offspring of identical
twins discordant for schizophrenia (Gottesman & Bertelsen 1989, Kringlen & Cramer
1989). In the Danish twin study, there was no significant difference in the morbid risk
of schizophrenia between offspring of affected twins (10%) and unaffected co-twins
(17%) (Gottesman & Bertelsen 1989). However, sample sizes were quite small: three
schizophrenic probands had a total of 14 offspring, 1 of whom was affected, while 6
unaffected cotwins had 24 offspring, 4 of whom were affected (Gottesman & Bertelsen
1989). The sample size in the Norwegian twin study was larger (Kringlen & Cramer
1989). Of the 28 offspring of schizophrenic twins, five (18%) had a schizophrenia
spectrum disorder, whereas 2 of the 45 offspring of unaffected co-twins had a
schizophrenia spectrum disorder (4%) (Kringlen & Cramer 1989). These differences
were not statistically significant (Kringlen & Cramer 1989). Although both of these
studies lacked statistical power, they suggest that unaffected monozygotic cotwins tend
to carry the genotype predisposing to schizophrenia, but that it remains unexpressed in
them – for example, because they have not been exposed to environmental risk factors
(Gottesman & Bertelsen 1989).
The studies of discordant monozygotic twins have also given clues about environmental
risk factors. The findings of higher concordance rates among monochorionic (twins
sharing the same placenta and chorion) than dichorionic monozygotic twins (Davis &
Phelps 1995), greater intrapair differences in finger ridge count among monozygotic
twins discordant for schizophrenia than among normal monozygotic twins (Bracha et al
1992), and higher frequency of serious perinatal complications in the affected co-twin
(Torrey et al 1994) suggest the involvement of prenatal environmental factors.
Twin studies, in summary, suggest that genetic factors are the most important risk
factors for schizophrenia. However, environmental factors are also important: less than
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half of individuals with an identical genome – identical twins – are concordant for
schizophrenia.
2.4.2.2. Adoption studies
Adoption studies compare the effects of different rearing environments among groups
that are assumed to be similar in their genetic predisposition, and the effects of different
genetic predisposition among groups that are assumed to have similar rearing
environments.
In the adoptees’ families design, the probands are adoptees who have developed
schizophrenia in adulthood and unaffected control adoptees. The psychiatric status of
the biological and adoptive relatives is investigated. If genetic factors are important, the
rate of schizophrenia should be higher among the biological than adoptive relatives of
an affected adoptee. If the rearing environment is important, more abnormalities should
be observed among the adoptive families of affected than unaffected adoptees.
(Gottesman & Shields 1982, pp. 76-77)
The largest study to use the adoptees’ families design was the Danish Adoption Study
of Schizophrenia (Kety et al 1994). This found significantly increased risks of DSM-III
schizophrenia, schizoaffective disorder, and schizotypal personality disorder among
biological relatives of probands with the same disorders than among relatives of control
probands, but no increased risk among adoptive relatives of affected vs. control
probands (Kety et al 1994, Kendler et al 1994).
In the adoptees method, the parent with schizophrenia is the proband. The identification
of probands can follow two paths. One starts with patients with schizophrenia who have
children, and locates those children who have been adopted. The alternative path
identifies all adoptees and selects those whose biological parent or parents have
schizophrenia. After the probands have been identified, the rate of occurrence of
schizophrenia among their adopted children is compared with the rate among adoptees
with unaffected biological parents. If genetic factors are important in the aetiology of
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schizophrenia, the rate of schizophrenia should be higher among those with an affected
biological parent. (Gottesman & Shields, pp. 75-76)
The largest and most recent study to use the adoptees method was the Finnish Adoptive
Study of Schizophrenia (Tienari et al 1994, Wahlberg et al 1997). The findings confirm
the genetic contribution in schizophrenia: 8.4% of the adopted offspring of probands
with schizophrenia developed a non-affective psychotic disorder compared with only
0.5% of the the adopted offspring of control probands (Tienari et al 1994). However, a
gene-environment interaction also emerged in the study (Wahlberg et al 1997). When
the adoptees were tested for schizophrenic thought disorder at the mean age of 21, only
those adoptees whose biological mother had had schizophrenia and whose adoptive
parents showed a high level of communication deviance displayed schizophrenic
thought disorder (Wahlberg et al 1997). This was not observed among adoptees who
only had a biological mother with schizophrenia or adoptive parents with a high level of
communication deviance (Wahlberg et al 1997).
Adoption studies confirm the importance of genetic factors in the aetiology of
schizophrenia. The Finnish Adoptive Study has provided evidence for gene-
environment interaction in the development of schizophrenia.
2.4.2.3. High-risk studies
The third method used to separate the contribution of genetic and environmental factors
in the aetiology of schizophrenia is the high-risk method, which is also feasible for
identifying early indicators of an emerging schizophrenia (Cornblatt & Obuchowski
1997). In high-risk studies, individuals who have a higher risk of developing
schizophrenia than those in the general population are identified in childhood and
followed up through the risk period for developing schizophrenia. Typically, high-risk
samples consist of offspring of schizophrenic parents. The best-known high-risk studies
of schizophrenia are the Copenhagen High Risk Project (Cannon & Mednick 1993), the
New York High-Risk Project (Erlenmeyer-Kimling et al 1997), and the Israeli High-
Risk Study (Ingraham et al 1995).
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The largest of the high-risk studies is the Copenhagen High Risk Project, which has
followed up 207 children born to mothers with chronic schizophrenia and 104 controls
with healthy parents for more than 30 years (Cannon & Mednick 1993). Their findings
again support the strong effect of genetic factors in the development of schizophrenia:
the prevalences among offspring of schizophrenic mothers vs. controls were 16.2% vs.
1.9% for DSM-III-R schizophrenia, 4.6% vs. 0.9% for DSM-III-R other nonaffective
psychotic disorders, and 21.3% vs. 5% for schizotypal, schizoid, and paranoid
personality disorders (Parnas et al 1993). However, they also found that offspring of
schizophrenic mothers who later developed schizophrenia had had significantly more
birth complications than high-risk subjects who remained unaffected (Parnas et al
1982). Offspring of schizophrenic mothers who had a schizophrenia spectrum
personality disorder had had less birth complications than those who had developed
schizophrenia and those who remained unaffected (Parnas et al 1982). Birth
complications interacted with genetic risk in determining cerebral ventricular
enlargement in high-risk subjects (Cannon et al 1993a). Severe instability in the early
rearing environment was another risk factor for schizophrenia among the high-risk
subjects (Cannon & Mednick 1993).
The New York High Risk Study includes, besides offspring of schizophrenic parents
and controls, a third group consisting of offspring of parents with a severe affective
disorder. The findings are of interest in relation to the diagnostic boundaries of the
schizophrenia spectrum. While schizophrenia and other nonaffective psychotic
disorders except schizoaffective disorder occurred only among offspring of
schizophrenic parents, RDC schizoaffective disorder, mainly schizophrenic type, was
more common and RDC schizoaffective disorder, mainly affective type, less common
among the offspring of parents with affective disorder than among those of
schizophrenic parents. Affective psychoses were equally common among both high-risk
groups. Otherwise, the New York High Risk Project has focused more on detecting
early biological and behavioural markers of schizophrenia than on identifying
environmental risk factors for schizophrenia. (Rosenberg et al 1997, Erlenmeyer-
Kimling et al 1997, Freedman et al 1998)
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The Israeli High-Risk Study consists of 50 offspring of schizophrenic parents, half of
whom were raised in a kibbutz, the other half by their biological parents, and 50 control
offspring of healthy parents similarly raised either in a kibbutz or by their biological
parents. Schizophrenia occurred only among high-risk subjects and equally among those
reared in a kibbutz or by their biological parents. (Ingraham et al 1995)
In Finland, Gunnel Wrede began a high-risk study of schizophrenia in the 1970s. Cases
had been born in Helsinki between 1960 and 1964 to schizophrenic mothers. The
mothers had been born between 1916 and 1948 and treated in Hesperia hospital for a
psychotic disorder. The children have not yet been followed up in adulthood, but they
did experience more pre- and perinatal complications than controls born in the same
hospitals (Wrede et al 1980). In adolescence, the children born to mothers with paranoid
schizophrenia were significantly better functioning socially than their peers from the
same class, while the social functioning of other high-risk subjects was slightly worse
than their peers. (Wrede 1984)
Results from high-risk studies provide strong support for the importance of genetic
factors in the development of schizophrenia, but they also emphasise the existence of
environmental risk factors and gene-environment interactions.
2.4.3. What is the mode of transmission?
The three simple Mendelian modes of inheritance are autosomal recessive, autosomal
dominant, and X-linked. In autosomal recessive inheritance, only probands who are
homozygotic for the disease allele are affected. Both parents of the affected probands
are usually unaffected but 25% of their siblings are affected. The proband’s children and
more distant relatives are rarely affected. In autosomal dominant inheritance, probands
who are heterozygotic for the disease allele are also affected. One of the proband's
parents is always affected, as well as 50% of siblings and children, and there is usually a
long family history of the disorder. The third mode is X-chromosome linked
inheritance, which is usually recessive; the X-linked dominant mode of inheritance is
extremely rare. A female with one X-linked recessive allele will not show the disease,
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but half of her sons will be affected, while half of her daughters will be unaffected
carriers. A male with an X-linked recessive allele can only have received the allele from
his mother. He cannot transmit the disease to his sons, but half of his daughters will be
unaffected carriers. (Gottesman & Shields 1982, pp. 60-62)
A new mutation class - the so-called dynamic mutations caused by unstable DNA -
identified in the beginning of the 1990s may obscure the otherwise Mendelian pattern of
inheritance. Unstable DNA consists of pathologically expanding DNA nucleotide
triplets. These DNA sequences display a marked tendency to amplify when transmitted
from parent to child. The person will remain asymptomatic until a certain number of
triplet repeats, after which symptoms start to emerge with increasing severity depending
on the number of repeats. Huntington’s disease and Fragile X syndrome are examples of
triplet repeat diseases. Typical of these diseases is a phenomenon called anticipation, a
tendency of symptoms to get worse and age at onset to become earlier from one
generation to the next. (Petronis & Kennedy 1995, O’Donovan & Owen 1996)
Besides single gene mendelian transmission, there are three other types of transmission
models: single major gene, oligogenic, and multifactorial polygenic. Single major gene
models suggest that there is one major gene which accounts for most of the genetic
transmission of a disorder, but other genes and environmental conditions may also have
some minor effect. Oligogenic models assume that there are several genes whose
combined action causes the illness. The action of the genes may be additive or
interactive (epistatic, meaning that the combined effect of the genes is more or less than
the sum of their separate effects). (Faraone & Tsuang 1995, p. 95)
Multifactorial polygenic inheritance means that a large number of genes of small effect
occur simultaneously and combine with environmental effects to determine the
outcome. The difference between oligogenic and multifactorial polygenic models is one
of degree: there are several, but perhaps less than ten, genes in the oligogenic model,
while there may be even hundreds of genes in the multifactorial polygenic model.
Polygenic inheritance is characterized by a clinical range of outcomes from borderline
to severely affected, by severely ill probands having more affected relatives than mildly
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ill probands, by the increasing risk to relatives with greater numbers of affected family
members, by a sharply decreasing risk from close to more distant relatives, and by a
distribution of cases on both maternal and paternal sides of a family. Multifactorial
polygenic models assume that the liability to develop a disorder is normally distributed,
and that individuals above a certain threshold manifest the disorder. There may be
different thresholds for mild and more severe forms of the disorder. (Gottesman &
Shields 1982 p. 63, Faraone & Tsuang 1995 pp. 95-96)
Analyses that assess the mode of transmission are called segregation analyses.
Unfortunately, they have not been successful in identifying the mode of transmission of
schizophrenia, and almost all modes of transmission have their supporters (Crow 1995,
Crow 1995a, Tsuang & Faraone 1995, Owen & Craddock 1996).
2.4.4. Where are the genes located? Molecular genetic studies
The search for genes conferring vulnerability to schizophrenia started in the 1980s with
linkage analysis studies of large, densely affected families (Kendler & Diehl 1993).
Initially, there were some promising findings in individual studies, but replication
studies failed to support the observed linkages (Kendler & Diehl 1993).
Developing methodology in the 1990s has made genomewide scans feasible, and a
number of genomewide scans have been conducted in recent years. The results,
summarized in Table 13, have been somewhat disappointing. Findings suggesting
linkage have been made in nearly all human chromosomes, but replications have been
rare. The most promising areas remain more or less a matter of opinion. Worldwide,
they might be located on the short arms of chromosomes 2, 6, 8, and 10. (Crow &
DeLisi 1998, DeLisi 1999, DeLisi & Crow 1999a)
As a part of The Genetic Epidemiology and Molecular Genetics of Schizophrenia in
Finland project, one genome scan and one study focusing on previously identified
linkages have recently been completed.
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In the genome scan conducted in pedigrees originating from a genetically isolated
community in Finland, the strongest evidence for linkage was obtained from
chromosome 1q (Hovatta et al 1999). Although none of the previous genomewide scans
have found evidence for linkage in this area, a balanced translocation strongly
associated with schizophrenia and other psychotic disorders has been found close to this
area in a Scottish pedigree (Devon et al 1998). The next promising area was on
chromosome 4q, where some evidence of linkage has been observed in previous
genomewide scans, although in an area somewhat proximal to this finding (DeLisi
1999). The third region with a lod score over two was located on Xp, where previously
weak evidence for linkage has again been observed (Hovatta et al 1999). In a study that
investigated candidate regions on chromosomes 3p, 5q, 6p, 20p, and 22q on an
independent sample of large Finnish pedigrees, some evidence for linkage was found on
chromosomes 5p, 6p, 8p, and 20p, although the maximum lod score did not exceed 2 in
any of the regions (Hovatta et al 1998).
Table 13. Positive findings on genome scans of schizophrenia
Chromosome Worldwide Finland Chromosome Worldwide Finland
1q + 10p +
2p + 10q +
2q + 12p +
4p + 12q +
4q + + 13q +
5p + 14q +
5q + 15p +
6p + 16q +
6q + 18p +
7q + 18q +
8p + 20q +
8q + 22q +
9q + Xp + +
+ means lod>2 or P<0.01
(Crow & DeLisi 1998, DeLisi & Crow 1999, Hovatta et al, in press)
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Genomewide scans are one strategy for identifying genes predisposing to schizophrenia.
Another widely used strategy is to study candidate genes. The problem with such
studies is that because the pathogenetic mechanism of schizophrenia is obscure, the
possibly defective biochemical pathways are not known. (DeLisi 1999)
Dopamine receptor genes have been widely studied. Except for increased homozygosity
of the D3 receptor among patients with schizophrenia, the findings have been negative.
Findings concerning N-methyl-D-aspartate receptors, catechol-O-methyltransferase and
apolipoprotein E4 have equally been negative. Controversial, weak positive findings
exist on the serotonin 2A receptor, α-7 nicotinic acetylcholine receptor, some HLA-
alleles, and a gene coding for an aspect of the potassium channel. Overall, candidate
gene studies conducted thus far have failed to identify any genes related to
schizophrenia. (DeLisi 1999)
Some rare chromosomal translocations and other chromosomal aberrations have been
linked with schizophrenia. A microdeletion on chromosome 22q11 causing the velo-
cardio-facial syndrome has repeatedly been associated with schizophrenia (Murphy &
Owen 1996, DeLisi 1999). Patients with the velo-cardio-facial syndrome or CATCH-22
have a 10-30% risk of developing nonaffective psychotic disorder (Murphy & Owen
1996). A few studies have detected balanced translocations or other chromosomal
aberrations in single pedigrees (Tsuang & Faraone 1995, DeLisi 1999). Some evidence
of the involvement of dynamic mutations in schizophrenia has also been obtained
(DeLisi 1999).
Overall, the findings from genetic studies are modest compared with the efforts
invested. There are, however, several reasons why this should be so. The uncertainty of
the correct phenotypic definition of schizophrenia or schizophrenia spectrum disorders,
incomplete penetrance, and genetic heterogeneity make schizophrenia even more
complex than most other complex disorders (Kendler & Diehl 1993). It may be that
there are no genes of major effect involved in the aetiology of schizophrenia (Owen &
Craddock 1996), and large family studies may not be the correct method to search for
genes of minor effect. Besides, densely affected pedigrees may actually be more likely
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to have multiple disease genes segregating than smaller ones (Owen & Craddock 1996).
Association studies and those focusing on genetic isolates have been offered as one
solution (Owen & Craddock 1996). It has also been suggested that hypothesis-driven
research should be emphasised more than the current approach of trying first to find the
gene and only after that the cause (DeLisi 1999).
2.5. Environmental risk factors of schizophrenia
2.5.1. Infections
There was already speculation about infections being involved in the aetiology of
schizophrenia back in Kraepelin’s and Bleuler’s times (Kraepelin 1919 pp. 240-241,
Bleuler 1911 pp. 343-344): the spirochete causing neurosyphilis had been identified,
and it seemed that the involvement of infections in the aetiology of schizophrenia at
least could not be ruled out. Psychotic symptoms associated with influenza infections
during the pandemic of 1918-1919 fuelled these speculations. The infectious aetiology
theory was then forgotten until findings of abnormalities in the immune system among
patients with schizophrenia, and observations that viruses were capable of causing new
symptoms decades after the primary infection, revived interest in the early 1970s.
(Yolken & Torrey 1995)
There are several hypotheses on how an infection could cause schizophrenia. It could be
a direct result of an active infection which disrupts cellular and molecular functioning.
Or a viral infection might act in a more subtle way, for example by mimicking CNS
transmitters or receptors. Schizophrenia could also be caused by a latent virus that is
periodically reactivated, or by retroviral genomic material integrated into host-cell
DNA. Finally, it has been suggested that it is the immune response, rather than an initial
infection, that is responsible for the development of schizophrenia. The suggested
timing of the infection varies from the prenatal period to the onset of schizophrenia.
(Kirch 1993)
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Indirect evidence for an involvement of infections comes from findings suggesting a
dysfunction of the immune system and from ecological studies. Abnormalities in the
immune system reported in patients with schizophrenia include alterations in peripheral
lymphocyte populations (Nikkilä et al 1995), an increased number of atypical peripheral
lymphocytes (Yolken & Torrey 1995), protein and immunoglobulin abnormalities in the
cerebrospinal fluid (CSF) (Ahokas et al 1985, Yolken & Torrey 1995), increased
frequency of antinuclear and other autoantibodies (Yolken & Torrey 1995, Spivak et al
1995), and various abnormalities in cytokine concentrations (Yolken & Torrey 1995,
Naudin et al 1997, Rothermundt et al 1998).
Ecological or population correlation studies compare cross-sectional population data for
both exposure and disease occurrence. In schizophrenia epidemiology, ecological
studies have been used to investigate whether infectious epidemics or other insults
during the prenatal development are associated with an increased risk of the later
development of schizophrenia. Ecological studies cannot prove a causal relationship but
they are particularly useful for hypothesis generation. (Breslow & Day 1987, p.4)
Several ecological studies have investigated the association between prenatal exposure
to influenza epidemics and later development of schizophrenia. Most (Mednick et al
1988, Barr et al 1990, Takei et al 1996a, O’Callaghan et al 1991, Kunungi et al 1995,
McGrath et al 1994, Takei et al 1995a), but not all (Torrey 1988, Susser et al 1992,
Erlenmeyer-Kimling et al 1994) have found an association between second-trimester
exposure to an influenza epidemic, especially the worldwide 1957 epidemic, and later
development of schizophrenia. The original finding was reported from Helsinki
(Mednick et al 1988), and the authors were able to locate prenatal clinic records from a
sample of mothers of patients who later developed schizophrenia. The mothers who had
been exposed to the influenza epidemic during the second trimester had reported
influenza-like infection significantly more often (87%, 13/15) than mothers who had
been exposed during the first or third trimester (20%, 2/10) (Mednick et al 1994).
Others have also observed that mothers of patients with schizophrenia who had had
influenza during gestation had had it significantly more often in the second than in the
first or third trimester (Wright et al 1995). It has been suggested that a proportion of the
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genetic predisposition for schizophrenia might be mediated by genes controlling the
maternal immune response to gestational influenza (Wright et al 1995). However, the
findings concerning the association between prenatal influenza and schizophrenia have
not been consistent; notably, the findings from the two cohort studies were negative
(Crow & Done 1992, Cannon et al 1996). Other infections have been investigated less
frequently, and replicated associations have generally not been found (Watson et al
1984, Torrey et al 1988, O’Callaghan et al 1994).
Direct evidence of an infection has been sought by studies on antibodies, antigens, and
the viral genomes. Studies on peripheral and CSF viral antibodies have sometimes
reported elevated concentrations of various antibodies, but consistent elevations against
a specific causal agent have not been detected (Ahokas et al 1987, Yolken & Torrey
1995). Findings concerning viral antigens and the viral genome have also usually been
negative (Yolken & Torrey 1995), recent results on Borna disease virus being an
exception.
Borna disease virus infects a broad range of warmblooded animals (Lipkin et al 1997).
It has a predilection for neurons of the limbic system, and it causes a variety of
neurological symptoms in affected animals but may also run a life-long latent course
(Bode et al 1988, Lipkin et al 1997). Increased prevalences of Borna disease-specific
antibodies have been found in psychiatric patients, both among those with affective
disorders (Bode et al 1988) and those with schizophrenia (Waltrip et al 1995, Iwahashi
et al 1997). Borna disease virus proteins have been detected in the CSF of patients with
major depression (Deuschle et al 1998), and Borna disease virus genome transcripts
from the postmortem brain samples of patients with schizophrenia and bipolar disorder
(Salvatore et al 1997). Although positive findings are limited to a small minority of
patients (2-10%), they are intriguing and certainly encourage study of the role of Borna
disease virus in the aetiology of schizophrenia and other mental disorders.
Enteroviruses belong to the picornaviruses, small RNA-viruses, and consist of polio
viruses, coxsackie viruses, echo viruses, and other enteroviruses (Hovi 1998).
Enteroviruses are good candidate agents for involvement in the aetiology of
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schizophrenia, because 1) they cause CNS infections: they are the most common cause
of viral aseptic meningitis and also cause encephalitis (Muir & van Loon 1997), 2) acute
infections may be accompanied by psychotic symptoms (Wang et al 1996), 3) they may
cause fetal infections leading to cerebral ventriculomegaly (Dommergues et al 1994), 4)
they may persist in the body for years (Hovi 1998), and 5) they may cause new
symptoms decades after the primary infection (Bruno et al 1994).
A contribution of a prenatal polio virus infection to the development of schizophrenia
has been suggested, because a decline in the incidence of schizophrenia occured in
many countries after the introduction of polio vaccination (Eagles 1992, Squires 1997).
It has been suggested that the winter-early spring excess of schizophrenic births is
caused by an infection during the second trimester of fetal development (Huttunen et al
1994). If so, polio virus epidemics, which peak in late summer and early autumn
(Nathanson & Martin 1979), are a better candidate to explain the seasonality than the
winter and spring infections usually suggested (Eagles 1992). There is also a similar
geographical variation in the seasonality of poliomyelitis epidemics (Nathanson &
Martin 1979) and schizophrenic births (Torrey et al 1977). Environmental survival of
polio viruses is very sensitive to both humidity and temperature (Nathanson & Martin
1979). In areas with high relative humidity and low variation in temperature, the annual
variation in the incidence of poliomyelitis was low, while it was very high in areas with
large temperature and humidity variations. In the United States, the seasonal variation in
the incidence of poliomyelitis was highest in the New England states and lowest in the
West South Central states (Texas, Louisiana, Arkansas, Oklahoma). Similarly, the
seasonal variation of births in schizophrenia was most pronounced in New England and
least pronounced in the southern United States (Torrey et al 1977). Further support for
the hypothesis comes from the latency of the effect of poliovirus. Decades after the
primary infection, new symptoms – the so-called post-polio syndrome - can emerge
(Bruno et al 1994, Dalakas 1995). Acute polio infection of the central nervous system
affects, besides motor neurons and motor cortex, the hypothalamus, thalamus,
cerebellum, and reticular formation in the brain stem, areas that partially correlate with
those in which brain lesions have been observed in schizophrenia (Bruno et al 1994,
Dalakas 1995a, Heckers 1997).
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Thus far, few studies have investigated the possible role of enteroviruses in the
aetiology of schizophrenia. Two previous studies have compared the incidence of
paralytic poliomyelitis and the number of schizophrenic births (Watson et al 1984,
Torrey et al 1988). The first detected no association (Watson et al 1984), while the
second found a significant coherence between schizophrenic births and poliomyelitis - a
finding difficult to explain because poliomyelitis preceded the schizophrenic births by
18 months (Torrey et al 1988). In neither of these studies was the place of birth of the
patients known. A third study found no relationship between the number of deaths
caused by poliomyelitis and schizophrenic births (O’Callaghan et al 1994) - however,
death is a rare outcome of polio virus infection. Rantakallio et al found that neonatal
meningitis caused by Coxsackie B5, another enterovirus, was associated with an
increased risk of adult schizophrenia (Rantakallio et al 1997).
2.5.2. Obstetric complications
The association between pre- and perinatal complications and later development of
schizophrenia has been convincingly demonstrated. Birth cohort studies, in which a
general population birth cohort born in a certain area in a limited time period has been
followed up from prenatal period until adulthood, have consistently found an
association between pre- and perinatal complications and later development of
schizophrenia (Sacker et al 1995, Hollister et al 1996, Jones et al 1998), although only
on a trend level in the American study (Buka et al 1993). In the Northern Finland 1966
Birth Cohort Study, low birth weight (<2500g), short gestation and low Apgar scores
after birth were associated with an increased risk of later development of schizophrenia.
Low birth weight was also found to be a risk factor in the British Perinatal Mortality
Survey (Sacker et al 1995). In the Danish Perinatal Cohort, Rhesus incompatibility
(mother Rhesus D-negative, child Rhesus D-positive) was a risk factor for
schizophrenia (Hollister et al 1996). The British Perinatal Mortality Survey also
observed that mothers of children who developed schizophrenia were more often
Rhesus negative than the mothers of other members of the cohort (Sacker et al 1995). In
a meta-analysis of all case-control studies conducted thus far, the pooled odds ratio for
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exposure to obstetric complications and subsequent development of schizophrenia was
2.0 (Geddes & Lawrie 1995).
Prenatal insult is also suggested by the excess of minor physical anomalies observed
among patients with schizophrenia, although these are at least partially determined by
genetic factors (O’Callaghan et al 1991a, Murphy & Owen 1996a, Ismail et al 1998). A
study of monozygotic twins discordant for schizophrenia found that they had greater
intrapair differences in finger ridges than normal control twins (Bracha et al 1992). This
is consistent with a second trimester insult affecting the two twins differently, because
differences in finger ridges mainly reflect differences in fetal size during the second
trimester (Bracha et al 1992). Extreme maternal stress (caused by loss of a spouse or
sudden outbreak of a war) during the second trimester of pregnancy has also been
associated with an increased risk of later development of schizophrenia (Huttunen &
Niskanen 1978, Van Os & Selten 1998).
The British Perinatal Mortality Survey also observed that the physique, mental health
and lifestyle of the mothers of children who later developed schizophrenia was
significantly different from that of other mothers (Sacker et al 1995). They were more
likely to have low weight before pregnancy, more often suffered from mental health
problems, more often smoked during pregnancy, made fewer visits to antenatal clinics,
and their average parity was greater (Sacker et al 1995). Mothers who have
schizophrenia have more pregnancy and birth complications than control mothers, and
the children of schizophrenic mothers more often have low birthweight and poor
neonatal condition (Wrede et al 1980, Sacker et al 1996). Therefore, the association
between obstetric complications and later development of schizophrenia might also
partially reflect characteristics of the mother instead of being a true risk factor for
schizophrenia (Sacker et al 1995).
2.5.3. Malnutrition
The effect of prenatal nutrition on the risk of later developing schizophrenia has been
investigated in the Dutch Famine Study (Susser et al 1998). This study has investigated
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the occurrence of various neurodevelopmental disorders among a cohort of children
who were exposed to severe famine while in utero during the winter of 1944-1945. The
German blockade in The Netherlands caused a severe famine that lasted from October
1944 to May 1945. Individuals who had been conceived during the height of the famine
between February and April 1945 and had thus been exposed to famine during the first
trimester showed a twofold increase in the risk of schizophrenia (Susser et al 1996) and
also an increased risk of schizoid personality disorder (Hoek et al 1996). Individuals
exposed to the famine during the second trimester of fetal development had an increased
risk of later developing affective psychosis, which was statistically significant in males
but not in females (Brown et al 1995).
2.5.4. Childhood rearing environment
Psychodynamic theories have considered disturbed early interaction between parents
and child to be an important factor in the development of schizophrenia (Alanen et al
1966, Alanen 1990). However, as a result of vast biological research the family
environment has been seen as less and less important; Weinberger stated in his 1995
Lancet review of the aetiology and pathophysiology of schizophrenia that ”decades of
scientifically unfounded psychological and social theories that blamed families and
society have given way to increasingly compelling scientific evidence that
schizophrenia is a brain disorder” (Weinberger 1995). Does the childhood rearing
environment, then, have any effect on the risk of developing schizophrenia? Several
recent studies suggest that the early rearing environment might indeed have such an
impact. In the 1946 British Birth Cohort Study, mothers of children who later developed
schizophrenia had worse than average general understanding and management of their
children, although none of them was known to be mentally ill (Jones et al 1994). In the
Northern Finland 1966 Birth Cohort, being a child from an unwanted pregnancy was
significantly associated with the later development of schizophrenia (Myhrman et al
1996). However, being from a single-parent family was not associated with the risk of
developing schizophrenia or other psychotic disorders (Mäkikyrö et al 1998a), neither
was maternal depression during pregnancy (Veijola et al 1998). In the Finnish Adoption
Study, schizophrenic thought disorder was observed only among those children whose
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biological mother had schizophrenia and whose adoptive parents showed high
communication deviance (Wahlberg et al 1997), a finding suggested in a previous high-
risk study (Miklowitz 1994). In the Copenhagen High-Risk Study, severe instability in
the early rearing environment was associated with an increased risk of adult
schizophrenia (Cannon & Mednick 1993). Thus, the possibility that the childhood
rearing environment might be a risk factor for – or a protective factor against – the later
development of schizophrenia should not be discarded.
2.6. Aetiological models of schizophrenia
It has been convincingly demonstrated that both genetic and environmental factors are
important in the aetiology of schizophrenia, but how do their effects combine to
produce the disorder? This problem of mechanism of action and interactions of genetic
and environmental risk factors is common to all aetiologic research on complex diseases
(Ottman 1996).
Kremen et al (1992) and Tsuang et al (1990) have presented alternative aetiological
models of schizophrenia and research strategies with which to test them. The strategies
to study vulnerability indicators of schizophrenia, such as birth complications or
cerebral ventricular enlargement, based on different aetiological models are the high-
risk method, the family study method, and the familial-sporadic strategy (Lewis et al
1987). In the latter, patients are divided into familial cases who have a positive family
history of schizophrenia or schizophrenia spectrum disorders, and sporadic cases, who
have no family history of schizophrenia spectrum disorders (Lewis et al 1987).
Aetiological models of schizophrenia fall into two broad categories: unitary models and
discrete subtype models. Unitary models can further be divided into multifactorial and
latent trait models. Multifactorial unitary models assume that schizophrenia is a
multifactorial disorder determined by a single set of aetiological factors that initiate the
same basic pathogenic processes. Phenotypic heterogeneity reflects quantitative
differences along a single continuum of severity. Latent trait models assume a common
factor underlying the single disease process, and observed variations in the phenotype
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are caused by pleiotropy. In contrast, discrete subtype models suggest that
schizophrenia can be subdivided into distinct disorders at the level of aetiology or
pathophysiology. (Kremen et al 1992)
The multifactorial polygenic model assumes that liability to schizophrenia is composed
of genetic and environmental risk factors that act in an additive fashion. If we are
studying an indicator that is thought to be environmental, for example birth
complications, the model suggests that familial probands will manifest less severity on
the indicator than sporadic probands, familial probands will manifest greater severity
than their relatives with milder schizophrenia spectrum disorders, and unaffected
relatives of familial probands will have the lowest severity. If the indicator is thought to
reflect genetic liability, the group with the greatest amount of genetic vulnerability will
manifest the greatest severity. Thus, familial probands should show greater severity on
the indicator than sporadic probands, relatives with schizophrenia spectrum disorders
should show less severity than familial probands but greater severity than the unaffected
relatives of familial probands, and unaffected relatives of familial probands should
show greater severity on the indicator than the unaffected relatives of sporadic
probands. (Kremen et al 1992)
The latent trait model is a single major locus model in which the pathogenic gene can
cause schizophrenia, or increased severity on the indicator, or both. The indicator is a
marker of the presence of the same genotype as the disorder itself. A strict single-gene
model has been proposed by Crow, who suggests that one human gene, that causing
cerebral asymmetry, contributes substantially to the predisposition to psychosis (Crow
1995, 1995a). This gene, according to Crow, is crucial to the development of language
and is associated with significant variation, which explains the variation in the
phenotype (Crow 1995a). The model excludes any environmental risk factors (Crow et
al 1995a). The model by Crow, although elegant, is not supported by the majority of
research findings (Tsuang & Faraone 1995, DeLisi 1999).
Kremen et al (1992) modified the latent trait model by suggesting that sporadic
probands are phenocopies and do not, therefore, have the genotype that produces the
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indicator. This modified model predicts that familial probands will manifest greater
indicator severity than sporadic probands, unaffected relatives of familial probands will
show greater severity on the indicator than unaffected relatives of sporadic probands,
and relatives with schizophrenia spectrum disorders will manifest equal indicator
severity to the familial probands themselves (Kremen et al 1992).
The interactive model suggests that some combination of pathogenic genes and
environmental risk factors is necessary for schizophrenia to develop. One variant of the
model is a multifactorial version, which suggests that if a threshold number of genes
with small additive effects is not passed, no amount of environmental liability is
sufficient for schizophrenia to develop. Another variant assumes that there is a single
pathogenic gene which alone causes mild schizophrenia spectrum disorder, and
schizophrenia develops only with enough additional environmental liability. Both of the
models predict the same findings. If it is assumed that the indicator is environmentally
caused, the familial probands will manifest the greatest severity on the indicator,
relatives of familial probands with schizophrenia spectrum disorders will manifest the
least indicator severity, and unaffected relatives of familial probands will show
intermediate indicator severity. The model does not allow for genetic differences
between familial and sporadic probands and no specific predictions can be made with
respect to sporadic probands. (Kremen et al 1992)
The discrete subtype model assumes that schizophrenia may be caused by either genetic
or environmental factors. If the indicator reflects some alternate, nongenetic cause of
schizophrenia, the model predicts that sporadic probands will manifest greater severity
on the indicator than familial probands, and no differences with respect to the indicator
among any of the groups of relatives because none of them has been subject to the
environmental factor associated with the indicator. (Kremen et al 1992)
There is also the possibility that the indicator is caused by the underlying
pathophysiological process of schizophrenia, in which case there should be no
difference in the severity of the indicator between familial and sporadic probands,
schizophrenia spectrum relatives of familial probands should show intermediate severity
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of the indicator between probands and unaffected relatives, and unaffected relatives of
both familial and sporadic probands should manifest minimal severity. If the indicator is
a result of being treated, only those probands, whether familial or sporadic, who have
been treated will have the indicator. (Kremen et al 1992)
How do findings from studies conducted thus far fit into these models? It seems likely
that none of the models will fit all cases with schizophrenia. For example, some rare
cases of schizophrenia seem to be caused by gross abnormalities in chromosomes
(Tsuang & Faraone 1995). Several different models are supported by the research.
Cerebral ventricular enlargement has been shown to be more prevalent among sporadic
than familial cases, especially among males (DeQuadro et al 1996, Murray & Jones
1995), supporting, in the absence of information on relatives, both the multifactorial
polygenic model with an environmental indicator and the discrete subtypes model. The
Copenhagen high-risk study found greater ventricular enlargement in high-risk subjects
with schizophrenia than high-risk and low-risk subjects with schizophrenia spectrum
disorders or no disorder (Cannon et al 1994). However, they also observed that among
the high-risk subjects, those who later developed schizophrenia experienced the greatest
number of obstetric complications, while those who later developed schizophrenia
spectrum disorders experienced the least, supporting the interactive model in the effect
of obstetric complications (Parnas et al 1982). In the determination of ventricular
enlargement, they found a linear increase in cerebral ventricles with increasing level of
genetic risk for schizophrenia, and an interaction between obstetric complications and
genetic risk: the effect of obstetric complications was largest among persons with two
affected parents (Cannon et al 1993a).
Different aetiological models may thus account for different aspects of the disorder, and
the extreme homogeneity model, which assumes that schizophrenia is caused by exactly
the same pattern of genetic and environmental factors, can be rejected (Tsuang &
Faraone 1995). Gottesman and Shields proposed a combined model, in which the
majority of cases would be caused by the combined effect of genetic and environmental
factors (Gottesman & Shields 1982, pp. 220-222). The genetic effect would mostly be
polygenic, but there might also be cases caused by a single major gene plus polygenic
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background. Besides these cases, there would be rare cases caused by single rare genes
or chromosomal abnormalities, and rare phenocopies caused entirely by environmental
factors (Gottesman & Shields 1982, pp. 220-222). This kind of model, which lets many
flowers blossom, would seem wise until proved otherwise.
2.7. Summary
Schizophrenia is a global disorder, but there is controversy over whether it also occurs
at similar frequency worldwide (Torrey 1989). The peak age at onset is early adulthood
(Sham et al 1994). It tends to occur more frequently – or at least at an earlier age –
among males than females (Castle et al 1995). Recent studies have suggested that the
incidence of schizophrenia is declining (Munk-Jørgensen 1995). These studies have
divided the opinion of researchers: some regard the findings as unreliable, caused
entirely by the operation of confounding factors such as narrowing diagnostic criteria,
while others believe that a genuine decline in the incidence has occurred (Geddes et al
1993, Kendell et al 1993, Harrison & Mason 1993, Munk-Jørgensen 1995). If the
decline is genuine, new information on the risk or protective factors of schizophrenia
may be gained by investigating what was happening when the incidence declined, or
when the cohorts whose incidence declined were born.
Both genetic and environmental factors have been shown to be important in the
aetiology of schizophrenia. Although the heritability of schizophrenia in different
populations has been high, no genes predisposing to schizophrenia have so far been
identified. Obstetric complications are the best supported environmental risk factor for
schizophrenia, but they are probably not themselves sufficient to cause it (Geddes et al
1995). Infections may also be involved in the aetiology of schizophrenia (Yolken &
Torrey 1995). Patients with schizophrenia have a seasonal variation of births that differs
from that of the general population (Torrey et al 1997), and persons born in urban areas
with high population density seem to have an increased risk of developing
schizophrenia (Mortensen et al 1999). The cause of both these phenomena is unknown,
but environmental risk factors has been suggested.
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 In Finland, many aspects of the epidemiology of schizophrenia have not been
previously studied; these include possible changes in incidence, and seasonal variation
of births in schizophrenia. However, we have a long tradition of aetiologic research on
schizophrenia (Alanen et al 1966, Mednick et al 1988, Tienari et al 1994), and research
on the genetic epidemiology of schizophrenia has advanced in recent years (Hovatta et
al 1997, Cannon et al 1998). Finland's stable, relatively isolated population and
excellent health-care registers are unique assets for epidemiologic research. Thus, this
study was set out to investigate epidemiological features and some risk factors of
schizophrenia in the Finnish population. The study focused on changes in the incidence
of schizophrenia, time trends in the seasonal variation of births in schizophrenia, the
association between prenatal exposure to poliomyelitis epidemics and later development
of schizophrenia, and the association between familial loading for psychotic disorders
and age at onset and outcome of schizophrenia.
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3. AIMS OF THE STUDY
The aim of this study was to investigate epidemiological features and some risk factors
of schizophrenia in a nationwide, register-based sample of Finnish patients with
schizophrenia. The study consisted of four original publications, the aims of which
were:
(I) To investigate the impact of high or low familial loading of schizophrenia or all
psychotic disorders on the age at onset of schizophrenia, duration of hospitalisations,
probability of receiving a disability pension because of schizophrenia, and mortality,
with a special interest on the modifying effect of sex.
(II) To investigate whether prenatal exposure to polio virus epidemics is associated with
an increased risk for later development of schizophrenia and whether the effect is
limited to a specific time during gestation.
(III) To investigate whether the incidence of schizophrenia has declined and if so,
whether the decline was caused by period-related confounding factors or by a true
cohort effect or both, and whether there were any sex differences in the decline.
(IV) To study whether there is seasonality of births among patients with schizophrenia
in Finland, and if so, whether there are any time trends in the magnitude of the
seasonality, and whether there is any association between seasonality and urban birth,
sex, and age at onset of schizophrenia.
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4. METHODS
4.1. The Genetic Epidemiology and Molecular Genetics of
Schizophrenia in Finland project
This study forms part of the collaborative project “The Genetic Epidemiology and
Molecular Genetics of Schizophrenia in Finland” run by the Department of Mental
Health and Alcohol Research and the Department of Human Molecular Genetics at the
National Public Health Institute. The project was initiated in 1988, and its principal
investigators are professors Jouko Lönnqvist and Leena Peltonen-Palotie. The aims of
the project are to characterize the epidemiology of schizophrenia in Finland, especially
genetic epidemiology, to investigate genetic and environmental risk factors of
schizophrenia and their interactions, and to identify ultimately at least one gene
predisposing to schizophrenia. The project was approved by the Ethics Committee of
the National Public Health Institute (25 May 1994, 7 October 1998) and by the Ministry
of Social Affairs and Health (2140/69/88, 105/07/98).
4.2. Subjects and registers
Three nationwide health care registers were used to identify all persons born between
1940 and 1969 who had developed schizophrenia before 1992: the Finnish Hospital
Discharge Register, and two registers of the Social Insurance Institution, the Pension
Register and the Free Medicine Register. Parents and siblings of these probands were
identified from the National Population Register. Information on the relatives was
linked back to the health care registers to obtain data on their hospital admissions,
pensions, and free medications.
The National Population Register records information on place of birth, place of current
residence, marital status, and first-degree relatives of each Finnish citizen. For persons
who have died since the establishment of the register the date of death is also registered.
The Finnish Hospital Discharge Register covers all public and private hospitals in
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Finland. For each inpatient stay, data on beginning and ending dates, primary and up to
three subsidiary diagnoses, and hospital identification code are listed. Also listed are the
type of referral and of follow-up treatment, whether the admission was voluntary and, if
not, the duration of non-voluntary treatment. The Pension Register indexes the
beginning and ending dates and the primary diagnoses for disability pensions. The Free
Medicine Register contains data on the diagnoses of persons receiving free outpatient
medication. The data in these registers were linked using the personal identification
number, which codes the date of birth and sex and is unique for each person.
Register information for this study was obtained for the years 1969-1991. ICD-8
diagnostic criteria and codes were used in all the registers before 1987. Between 1987
and 1991, psychiatric diagnoses were coded according to ICD-9, applying DSM-III-R
diagnostic criteria. The Social Insurance Institution registers only the first three digits of
diagnostic codes. Therefore, we accepted all probands having a 295 diagnosis according
to the ICD-8 and ICD-9 codes. Besides core schizophrenia, this includes patients with
schizophreniform and schizoaffective disorders, and also patients with simple and latent
schizophrenia treated before 1987.
These registers allowed us to identify 30 339 patients with schizophrenia born between
1940 and 1969, 27 098 of whom (89%) had at least one hospitalization with a diagnosis
of schizophrenia. The real proportion of patients with at least one hospitalisation is
higher, because information from the Finnish Hospital Discharge Register was obtained
from 1969 onwards, when patients from the oldest cohort were already 29 years old.
There were 16 926 males (56%) and 13 413 females.
Family information was found for 24 657 patients, whereas it could not be located for
5682 patients. Of the patients without family information, 4728 had been born between
1940 and 1949, 883 between 1950 and 1959, and 71 between 1960 and 1969. Of the
95 719 identified first-degree relatives, 41 692 were parents, 53 586 siblings, and the
remaining 441 other relatives, usually grandparents.
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In this study, only subjects born between 1950 and 1969 were investigated. Subjects
born in the 1940s were excluded because the first hospitalisation, and therefore the age
at onset, could not be reliably determined and because of the large amount of missing
family information. There were 16 687 patients with schizophrenia born between 1950
and 1969. Of them, 15 398 (92%) had had at least one hospitalisation with a diagnosis
of schizophrenia. Disability pension because of schizophrenia had been granted to 9394
(56%) of the patients, and free antipsychotic medication for schizophrenia before 1987
to 8848 (53%) of them. Between 1987 and 1991, 4017 (24%) additional patients had
received free antipsychotic medication, but the exact diagnosis was no longer registered.
Family information was found for 15 733 patients (94%).
Of the 1289 patients with no hospitalisation for schizophrenia, 611 had free
antipsychotic medication and disability pension, 202 only had disability pension
because of schizophrenia and 470 only had free antipsychotic medication because of
schizophrenia; 403 (31%) had had at least one hospitalisation because of another
psychotic disorder.
Age at onset was defined as the age at the beginning of first hospitalisation for
schizophrenia or age at the beginning of first hospitalisation for any psychotic disorder.
The latter was considered to be a closer approximation of the true age at onset. In one of
the publications, the age when the person had started to receive the pension minus one
year was used to approximate the age at onset among patients who had had no
hospitalizations but received disability pension because of schizophrenia.
4.3. General population information
The Population Register Centre provided sex-specific, monthly numbers of births in
each Finnish municipality from 1940 to 1969 as multidimensional tables, with sex and
year, month and place of birth as marginals. A large number of birth cohorts was thus
formed, each consisting of males or females born in the same municipality during one
month of a particular year. From each of these the number of deaths up to 1969 and the
annual number of deaths from 1970 to 1991 were obtained.
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 4.4. Data on infectious diseases
We obtained the monthly Reports on Infectious Diseases originally kept by the National
Board of Health, stored in the archives of the National Research and Development
Centre for Welfare and Health. These were based on the reports delivered by every
Finnish physician to the National Board of Health. Each physician was required to
report the cases of infectious diseases they had treated (Lääkintöhallitus YK 1163). A
separate, detailed report on each case was required for some diseases, including
poliomyelitis, while the weekly number of treated cases was enough for others, for
example influenza. The reports were obtained for the years 1950-1969, and included the
monthly numbers of infections separately for each province and for the three largest
towns (Helsinki, Tampere, Turku) in Finland. In this study, we used the monthly
numbers of new cases of paralytic poliomyelitis.
4.5. Statistical methods
4.5.1. Familial loading, age at onset and outcome
We set out to study the effect of familial loading for schizophrenia on the age at onset
and outcome by comparing two extreme groups with each other, one with an extremely
high and another with an extremely low familial loading, along with a third group
representing the majority of patients with schizophrenia. The study population consisted
of all patients with schizophrenia born between 1950 and 1969 with available family
information (n=15 733). The study used the familial / sporadic distinction as a research
strategy (Lewis et al 1987), but the definitions of both familiality and sporadicity were
more stringent than in previous studies (Roy & Crowe 1994).
To estimate the familial loading of the patients we used the familial loading score
designed by Pak Sham (Verdoux et al 1996), which takes account of family size and age
structure. Familial loading score was based on the following assumptions: the lifetime
risk of schizophrenia in a first-degree relative is 10 per cent for familial probands and
0.5 per cent for sporadic probands. The age range at risk is 15 to 50 years, during which
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period the risk increases linearly from zero to the lifetime risk. The likelihood ratio of a
proband being familial or sporadic, given that a relative of age x is affected, is:
The likelihood ratio if a relative of age x is unaffected is:
Thus, the likelihood ratio for affected relatives is independent of the relative’s age but
for unaffected relatives it depends on age at the end of the follow-up period, which in
this study was 31 December 1991 or the date of death. The likelihood ratio was
calculated for each relative, and an overall likelihood ratio for whether the proband was
familial or sporadic was obtained by multiplying together the individual likelihood
ratios. Finally, the familial loading score was obtained by taking the logarithm of the
product. The natural logarithm was used in this study, while Verdoux et al used the
common logarithm. A negative score means that the proband has no affected first-
degree relatives. (Verdoux et al 1996)
For each patient, a familial loading score was calculated for schizophrenia (ICD 8 295)
and for all psychotic disorders (ICD 8 291-299). The ICD 291-299 categories are
alcoholic psychoses, drug psychoses, transient organic psychotic disorders, other
organic psychotic conditions, schizophrenic psychoses, affective psychoses, paranoid
states, other nonorganic psychoses, and psychoses with origins specific to childhood
(WHO 1967). The range of the familial loading scores was -1.0 to 23.8 for all psychotic
disorders and -1.0 to 20.7 for schizophrenia. Of the 15 733 patients with available
family information, 3427 (22%) had a positive loading score for schizophrenia, i.e., at
least one first-degree relative with schizophrenia, and 5489 (35%) had a positive
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loading score for all psychotic disorders, i.e., at least one first-degree relative with any
psychotic disorder.
The patient population was divided into three groups based on their familial loading.
Patients from families with at least three first-degree relatives with schizophrenia were
classified as having high familial loading for schizophrenia (loading score for
schizophrenia >4.0), and patients with the lowest loading score for all psychotic
disorders as having low familial loading for psychosis (loading score for psychoses
<-0.5). All the other patients were classified as having intermediate familial loading.
Hereafter, the group with high familial loading will be called the familial group, the
group with low familial loading the sporadic group, and the group with intermediate
familial loading the intermediate group.
The familial group consisted of 761 patients, the sporadic group of 725 patients, and the
intermediate group of 14 247 patients. The proportion of males and females in each
group did not differ significantly ( χ 2 =5.48, d.f.=2, P=0.065). The mean number of
siblings of patients was 5.7 in the familial group, 7.4 in the sporadic group, and 3.5 in
the intermediate group. The proportion of patients born in the 1960s was smallest in the
sporadic group and largest in the intermediate group ( χ 2 =99.8, d.f.= 2, P<0.001) and
because of this, year of birth was adjusted for in the analyses. The cases in the familial
group came from families with an average of 3.3 affected first-degree relatives.
Outcome was measured by the annual duration of hospitalisation, risk of receiving a
disability retirement pension, and mortality. We calculated the annual duration of
hospitalisation by dividing the number of days spent in hospital during the follow-up
period by the number of follow-up years.
The age at onset and the duration of hospitalisation were modelled with linear mixed
models, where sex, category of familial loading, and an indicator variable for being the
first to develop schizophrenia in the family were used as fixed explanatory variables,
and family was used as a random effect to account for the correlation between siblings
(Laird & Ware 1982). The variable "first to develop schizophrenia in the family" was
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included to control for the possibility that patients already having an affected family
member might have a shorter interval between the occurrence of psychotic symptoms
and first hospitalisation.Year of birth was controlled for in the analyses. Because early
onset is associated with higher risk of rehospitalisation (Eaton et al 1992), age at onset
was used as an explanatory variable in the model for the duration of hospitalisation.
Interaction between sex and familial loading was included when significant.
The risk of receiving a disability retirement pension, and mortality were modelled with
the Cox proportional hazard model (Cox & Oakes 1994). Follow-up was from the onset
of the disease until the event in question, the censoring date of these analyses being the
end of 1991. In these models age at onset, sex, and category of familial loading were
used as explanatory variables.
The level of significance in the models was determined by the Wald χ 2 -test.
4.5.2. Prenatal exposure to polio epidemics
When studying the association between prenatal exposure to polio epidemics and
subsequent schizophrenia, the study population was limited to births between 1951 and
1969, because the polio epidemics data was from 1950 to 1969.
It was assumed that the monthly number of births of individuals who later developed
schizophrenia in each province followed the Poisson probability model. This model
assumes that the number of new cases of schizophrenia (c) occurring in a particular age-
time-exposure cell takes on the values k=0, 1, 2, ... with probabilities
where λ denotes the unknown rate and n the person-years. The numbers of new cases
occurring in different cells are regarded as statistically independent. (Breslow & Day
1987, p. 131)
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To analyse the possible association between prenatal exposure to polio virus epidemics
and later development of schizophrenia, we used a Poisson regression model with the
number of schizophrenic births as a response variable, and geographical area, birth
cohort, age, sex, month of birth, and incidence of paralytic poliomyelitis as explanatory
variables. Circular transformation (Batschelet 1981) was applied to the month of birth to
analyze seasonal variation. The population size in each cell was used as weight to obtain
correct estimates.
The high variability in monthly incidence of poliomyelitis by province caused by small
numbers in most cells was smoothed using a moving average with a three month
window. The incidence of poliomyelitis was then dichotomized to an indicator variable
(0= no cases of poliomyelitis, 1=any cases of poliomyelitis). To test whether the effect
of polio epidemics increased along with the severity of the exposure, the incidence of
poliomyelitis was also divided into deciles; the first six deciles, in which the incidence
was zero, were pooled.
The incidence of schizophrenic births was modelled with and without the incidence of
polio. The improvement in model fit was tested using a χ2 likelihood ratio test.
4.5.3. Time trends in the incidence
We limited the study of time trends in the incidence of schizophrenia to persons born
between 1954 and 1965 to permit us to reliably identify the age at onset and to allow
identical follow-up times for each cohort. Each person was followed from the 16th
through 26th birthday. Those born outside Finland or of unknown birthplace were
excluded. Patients had to have received the first diagnosis of schizophrenia between
their 16th and 26th birthday. However, age at onset was defined as age at the beginning
of the first hospitalisation for any psychotic disorder excluding psychotic disorders
caused by alcohol or substance abuse, because it is a closer approximation of the time of
emergence of first psychotic symptoms than the age at the beginning of first
hospitalisation for schizophrenia. In addition, patients for whom disability pension
because of schizophrenia had been granted somewhere between their 16th and 26th
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birthday and who were hospitalized for any psychotic disorder at that age were also
included. Their age at onset was also defined as age at the beginning of the first
hospitalisation for any psychotic disorder. Persons who received the first diagnosis of
schizophrenia after the 26th or before the 16th birthday were not included in the sample
because the available follow-up time was not identical for all cohorts. These patients
were identified from the registers and their numbers in each cohort compared to
estimate whether their exclusion caused any bias. We also excluded patients with no
hospitalizations, because a meaningful age at onset could not be defined. Their numbers
allowed us to estimate the proportion of patients treated as outpatients in each cohort.
Age-specific incidences in each cohort and period were first calculated using exact
person-years at risk for each cohort. Period refers to the year of onset, and cohort to the
year of birth. Age, period, and cohort were each divided into 2-year intervals.
4.5.3.1. Age-period-cohort analysis
Time trends in the incidence of a disease may provide important clues to its aetiology.
The three time factors of interest are age, period (date of diagnosis), and cohort (date of
birth), and the analysis method by which the effects of these three factors on incidence
is estimated is called age-period-cohort analysis, and is widely used in cancer
epidemiology (Holford 1991, McNally et al 1997, Robertson & Boyle 1998). In
psychiatric research it has been used to study time trends in the incidence of major
depression (Klerman 1988, Wickramaratne 1989) and in suicide rates (Moens et al
1987, Granizo et al 1996), while only one previous study has used the method to assess
time trends in the incidence of schizophrenia (Takei et al 1996).
The problem with this method arises because age, period, and cohort are linearly
dependent: knowing any two of them, the third can be calculated. For example, if we are
currently living in 1999 and we meet a 30-year-old man, we know that he has been born
in either 1968 or 1969. This linear dependence means that the linear effects of age,
period, and cohort cannot be separated, because there is no unique set of regression
parameters. Different methods to overcome this nonidentifiability problem have been
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suggested. The only ones that avoid using arbitrary constraints or making strong
assumptions about the effects of age or cohort are those that do not attempt to separate
the effects of cohort and period on the linear component of the change but only estimate
deviations from linearity. We have used one of these methods, that of Clayton and
Schifflers. (Clayton & Schifflers 1987, Holford 1991, Robertson & Boyle 1998)
Clayton and Schifflers avoid the nonidentifiability problem by estimating solely the
curvature effects of period and cohort, which can be reliably estimated. They introduced
the term “drift” to describe the sum of linear cohort and period effects. Drift cannot be
partitioned into linear cohort and linear period effects and is therefore not usually
reported. After fitting the drift term, the curvature effects of age, cohort and period can
be reliably estimated. The underlying model used is the Poisson regression model with
standard Poisson assumptions (see 4.5.2.). The effects of age, period, and cohort are
assumed to be multiplicative. (Clayton & Schifflers 1987)
Curvature or “non-drift” effects operate in such a way that the relative risks between
adjacent cohorts (or periods) are not identical. They are calculated as contrasts between
relative risks in adjacent periods or cohorts:
where βi denotes the Poisson regression parameter estimates and i the distinct periods
(or cohorts). On the logarithmic scale, these contrasts are second derivatives, βi+1-2 βi+
βi-1. Although there are also other methods to calculate the curvature effects, these
second derivatives have the advantage that their value is affected only by neighbouring
data. (Clayton & Schifflers 1987)
Besides age, period, and cohort, the Poisson regression model used in this study
included as explanatory variables sex and seasonal variation of births. Seasonal
variation of monthly number of births was modelled using the method of Jones et al,
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which allows an arbitrary shape for the seasonal effect by representing the data as a
short Fourier series (Jones et al 1988). Only the first harmonic was found significant,
and was entered into the main model as “seasonality”. The model included all main
effects and all two-variable interactions involving sex. The significance of each
explanatory variable, after adjusting for the effect of other variables, was assessed by
comparing the full age-period model with one including all other variables except that
whose significance was tested. The goodness of fit of the models was compared using
χ2 likelihood ratio tests.
4.5.4. Time trends in the seasonal variation of births in schizophrenia
The life table data used in the analyses of seasonality of births among patients with
schizophrenia were constructed using month of birth, sex, place of birth (urban or rural),
age at onset, and birth cohort as marginals. The study population was individuals born
between 1950 and 1969.
Age at onset was defined as age at the beginning of the first hospitalisation for any
psychotic disorder (ICD-8 and ICD-9 295-299). If a person had no hospitalizations but
received disability pension because of schizophrenia, the age when he or she started to
receive the pension minus one year was used to approximate the age at onset. The one-
year subtraction was made because disability pension can be granted only after a one-
year period of sickness allowance. For the regression analyses, age at onset was grouped
into five categories: 16-20, 21-25, 26-30, 31-35, and 36-41. The birth cohort was
grouped into four categories: 1950-1954, 1955-1959, 1960-1964, and 1965-1969. Place
of birth was categorized as urban or rural; urban meant being born in Helsinki, Tampere
or Turku, the only towns in Finland with populations exceeding 50 000 throughout the
study period.
The life table data used in the analyses were constructed using month of birth, sex, place
of birth (urban/rural), age at onset, and birth cohort as marginals. Unadjusted risk ratios
for the incidence of schizophrenia were first calculated separately for each of these
explanatory variables.
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We then used the Poisson regression model to analyse the seasonal variation further.
The main model without seasonal variation was fitted using sex, age group, birth cohort,
and place of birth as explanatory variables. A linear time trend and all its significant
two-variable interactions with sex, age, cohort, and place of birth were then added.
After this, the seasonal variation was added by fitting a short Fourier series to the model
(Jones et al 1988). The first harmonic was fitted first, and higher harmonics were then
added when significant. The time interval 0 to T was divided into k intervals, where
t0=0 and tk=T. In this study, the birth cohorts span 20 years. T was therefore 240 months
and k 240. The fundamental period of the seasonality model (P) was 12 months. The
intensity, λ(t), of the Poisson process that is a time trend and a simple harmonic curve
was for group i:
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where ai was a parameter that allows the size of each group to be arbitary, bi(t-T/2) was
the trend which was centered for computational reasons, ci was the amplitude of the
cyclic curve, and Φi was the phase angle. The formula for the cosine of the two angles,
2πt/P and Φi , was for computational reasons rewritten as:



+


=

 Φ+
P
t
P
t
P
tc iiii
πβπαπ 2sin2cos2cos
where ( )iii c Φ= cosα  and ( )iii c Φ−= sinβ . When higher harmonics were added, the
intensity function became
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where h denotes the ordinal number of the harmonic (first, second, etc.)
The first harmonic and its two-variable interactions with sex, age, cohort, place of birth,
and trend were first fitted and their significance tested. The adding of higher harmonics
and their interactions with background variables was then continued until no significant
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increase in the model fit was observed. The significances of variables and interaction
terms were tested using log likelihood ratio tests with χ2 distribution.
The STL method, Seasonal and Trend decomposition using Loess (locally weighted
regression), was used to visualize year-to-year fluctuation in the seasonal variation of
births in schizophrenia. The STL procedure decomposes an incidence time series into
three components: trend, seasonal, and remainder. Trend is the linear change in the
incidence. After trend has been removed, seasonal variation and changes in its
amplitude are more easily discernible. The remainder consists of residuals from the
model, which describe other than seasonal or linear trend variation in the incidence.
Ideally, residuals consist solely of random variation, but they may also reveal other
systematic variation. The STL is quite robust in detecting both trends and seasonal
variation. (Cleveland et al 1990)
All statistical analyses were performed with the statistical software S-PLUS, version 3.4
(MathSoft, 1996).
89
5. RESULTS
5.1. The effect of familial loading on the age at onset and outcome
Characteristics of the groups are presented in Table 14. The mean ages at onset of
psychosis were 23.2 (standard deviation (SD) 4.9) years in the familial group, 23.7 (SD
5.1) years in the intermediate group, and 25.2 (SD 5.3) years in the sporadic group. The
corresponding mean ages at onset of schizophrenia were 23.7 (SD 5.2), 24.3 (SD 5.4)
and 25.8 (SD 5.7) years.
Table 14. Characteristics of the familial, intermediate, and sporadic groups
Familial group Intermediate group Sporadic group
Females Males Females Males Females Males
Number of
probands 307 454 6012 8235 334 391
Year of birth:
1950-1954 142 (46%) 217 (48%) 2381 (40%) 3320 (40%) 173 (52%) 210 (54%)
1955-1959 94 (31%) 146 (32%) 1849 (31%) 2488 (30%) 113 (34%) 126 (32%)
1960-1964 56 (18%) 69 (15%) 1142 (20%) 1597 (19%) 43 (13%) 44 (11%)
1965-1969 15 (5%) 22 (5%) 640 (11%) 830 (10%) 5 (2%) 11 (3%)
Age at onset1:
Schizophrenia 23.1 (SD 5.1) 24.1 (SD 5.3) 24.4 (SD 5.5) 24.2 (SD 5.3) 25.8 (SD 6.0) 25.8 (SD 5.4)
Psychosis 22.6 (SD 4.7) 23.7 (SD 5.0) 23.7 (SD 5.2) 23.7 (SD 5.0) 25.1 (SD 5.6) 25.3 (SD 5.2)
Annual duration of
hospitalisations2 73 (SD 82) 65 (SD 76) 59 (SD 74) 65 (SD 77) 50 (SD 66) 51 (SD 69)
Retired 219 (71%) 325 (72%) 3548 (59%) 5213 (63%) 200 (60%) 254 (65%)
Deaths 34 (11%) 82 (18%) 820 (14%) 1452 (18%) 52 (16%) 66 (17%)
1years
2days
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There was no sex difference in the mean age at onset of schizophrenia (males 24.2 (SD
5.3) years, females 24.4 (SD 5.5) years) or of psychosis (males 23.7 (SD 5.0) years,
females 23.8 (SD 5.3) years). However, the age at onset of schizophrenia distributions
did show sex differences. Among males, the distributions were unimodal and similar in
shape among all the groups, but the peak was earliest in the familial and latest in the
sporadic group. Among females, the first peak occured at approximately the same age in
the early twenties in all the groups, but was considerably sharper and declined rapidly in
the familial group. The age at onset distribution in the sporadic group was bimodal, with
a second peak in the late twenties.
In the linear mixed model, being first to develop schizophrenia in the family predicted
an earlier onset. When adjusted for the year of birth, order of developing schizophrenia,
and sex, the age at onset was, compared with the sporadic group, one year earlier in the
intermediate group and 3.3 years earlier in the familial group. The intraclass correlation
of the age at onset among siblings was 0.28 (P<0.001).
To assess whether this effect of familial loading on the age at onset is continuous, we
divided the sample into deciles based on the familial loading score. When familial
loading score for schizophrenia was used, the first seven deciles consisted of patients
with no affected relatives, among whom the effect of familial loading was not
continuous: a significant difference was observed only between the first and the other
deciles. Deciles 8 to 10 consisted of patients with at least one affected relative, and in
these groups the age at onset decreased significantly with increasing familial loading
score. The results were similar when the familial loading score for psychosis was used.
We also explored the relationship between age at onset and number of affected siblings
in the family. The results show that the age at onset decreased with rising number of
affected siblings (Table 15).
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The mean annual duration of hospitalisation after the onset was 68 (SD 78) days in the
familial group, 62 (SD 76) days in the intermediate group, and 51 (SD 68) days in the
sporadic group. The mean annual duration of hospitalisation was 59 (SD 74) days for
females and 64 (SD 77) days for males. The linear mixed model detected no interaction
between sex and familial loading, although the annual duration of hospitalisation in the
familial group was longer among females than males (Table 14). Being first to develop
schizophrenia in the family was not associated with the duration of hospitalisation.
Later age at onset and female sex predicted shorter hospitalisation. Compared with the
sporadic group, belonging to the intermediate and familial groups predicted
significantly longer hospitalisation, and belonging to the familial group predicted
significantly longer hospitalisation than in the intermediate group. When the age at
onset was excluded from the model, the effect of familial loading was similar but the
differences between the groups became more significant. The intraclass correlation of
duration of hospitalisation in siblings from the same family was 0.76 (P<0.001).
The risk of receiving a disablity retirement pension was highest in the familial group.
Females had a significantly lower relative risk of retirement. Not being first to develop
schizophrenia in the family was associated with lower risk of retirement. No interaction
Table 15. Number of affected siblings in the family and patient's
age at onset of schizophrenia 
Number of Mean age Number of Patients with no 
affected siblings at onset patients hospitalisations
1 24.4 (SD 5.4) 12308 1023
2 24.1 (SD 5.2) 1811 144
3 23.7 (SD 5.3) 297 35
4 23.6 (SD 5.4) 77 4
5 22.7 (SD 3.7) 16 2
6 21.1 (SD 3.5) 10 0
8 22.2 (SD 3.9) 6 0
Trend-tested F=12.6, P<0.001
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between sex and familiality was detected. Mortality was significantly lower among
females (relative risk (RR) 0.74, 95% confidence interval (CI) 0.67-0.80), and later age
at onset was associated with higher mortality (RR 1.10, 95% CI 1.09-1.11). However,
the degree of familial loading was not related to mortality.
5.2. Prenatal exposure to polio epidemics
The incidence of paralytic poliomyelitis showed very high variability, because even
during epidemics there were few cases in one province. The high variability was first
reduced by dichotomizing the incidence to an indicator variable (0= no cases of
poliomyelitis, 1=any cases of poliomyelitis). In another analysis, a moving average with
a three-month window was used before dichotomization. To investigate whether the
effect would increase with the severity of exposure, the incidence of poliomyelitis was
also divided into deciles; the first six deciles, in which the incidence was zero, were
pooled.
In the first regression model, in which the incidence of poliomyelitis was dichotomized
but not smoothed, exposure to poliomyelitis epidemics 5-6 months before birth was
associated with a significantly increased risk of later developing of schizophrenia
(RR 1.06, 95% CI 1.01-1.11). When seasonality was omitted from the model, the
relative risk increased slightly (RR 1.07, 95% CI 1.02-1.12).
When a smoothed incidence of poliomyelitis was used, exposure to a polio epidemic
5 months before birth was associated with an increased risk of later developing
schizophrenia (RR 1.05, 95% CI 1.00-1.11). When seasonality was omitted from the
model, the effect became significant throughout the second trimester (RR 1.06-1.08
4-6 months before birth).
The effect did not, however, increase with the severity of exposure. The relative risk of
developing schizophrenia compared with the first six deciles with no exposure was 1.13
in the seventh, 1.05 in the eight, 0.98 in the ninth, and 1.05 in the tenth decile.
93
5.3. Changes in the incidence
The incidence of schizophrenia peaked in the 20-21-year age group in both sexes, and
no sex differences in the onset age were found. Males had 31% higher incidence than
females. Incidence declined significantly in successive cohorts, from 0.79 per 1000
person years among males and 0.58 per 1000 person years among females in the 1954-
1955 cohort to 0.53 and 0.41 per 1000 person years, respectively, in the 1964-1965
cohort. There were differences in the pattern of decline in individual age groups, and in
some age groups the incidence actually rose before it started to decline, but the overall
decline in each age group was of the same magnitude among both sexes. (Table 16)
Table 16. Age-specific incidences of schizophrenia per 1000 person years
in cohorts born in 1954-1965 
Age groups
Cohort 16-17 18-19 20-21 22-23 24-25 All 
Males
1954-1955 0.34 0.92 0.91 0.99 0.77 0.79
1956-1957 0.32 0.77 0.86 0.91 0.82 0.74
1958-1959 0.25 0.53 0.74 0.81 0.99 0.66
1960-1961 0.25 0.65 0.90 0.74 0.62 0.63
1962-1963 0.19 0.50 0.82 0.61 0.63 0.55
1964-1965 0.19 0.55 0.62 0.71 0.57 0.53
All Cohorts 0.26 0.66 0.81 0.80 0.74
Females
1954-1955 0.33 0.64 0.63 0.63 0.69 0.58
1956-1957 0.35 0.61 0.67 0.65 0.56 0.57
1958-1959 0.16 0.39 0.73 0.74 0.56 0.51
1960-1961 0.20 0.38 0.63 0.50 0.53 0.45
1962-1963 0.22 0.40 0.55 0.60 0.37 0.43
1964-1965 0.19 0.44 0.55 0.44 0.44 0.41
All Cohorts 0.24 0.48 0.63 0.60 0.53
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Table 17. Age-specific incidences of schizophrenia per 1000 person years among  
cohorts born in 1954-1965 according to age and period of first diagnosis
Age groups
Period 16-17 18-19 20-21 22-23 24-25 All
Males
1970-1971 0.26 - - - - 0.26
1972-1973 0.32 0.89 - - - 0.57
1974-1975 0.32 0.86 0.96 - - 0.70
1976-1977 0.26 0.52 0.84 0.96 - 0.64
1978-1979 0.21 0.63 0.77 0.98 0.73 0.67
1980-1981 0.19 0.59 0.86 0.79 0.85 0.66
1982-1983 0.23 0.52 0.83 0.80 1.0 0.76
1984-1985 - 0.58 0.67 0.64 0.63 0.64
1986-1987 - - 0.63 0.66 0.62 0.64
1988-1989 - - - 0.66 0.60 0.64
1990-1991 - - - - 0.53 0.53
Females
1970-1971 0.29 - - - - 0.29
1972-1973 0.36 0.66 - - - 0.49
1974-1975 0.23 0.55 0.66 - - 0.47
1976-1977 0.18 0.53 0.63 0.65 - 0.49
1978-1979 0.22 0.36 0.71 0.57 0.67 0.50
1980-1981 0.18 0.41 0.61 0.79 0.61 0.52
1982-1983 0.27 0.40 0.64 0.51 0.58 0.52
1984-1985 - 0.51 0.52 0.62 0.49 0.54
1986-1987 - - 0.62 0.49 0.43 0.48
1988-1989 - - - 0.38 0.45 0.43
1990-1991 - - - - 0.35 0.35
Because the data were cohort-based, the age groups were not equally represented in
each period. Only the periods from 1978 to 1983 included all age groups, those aged
16-19 years represented by cohorts born in the 1960s and those aged 22-25 years by
cohorts born in the 1950s. In these periods, the incidences were quite low among the
16-19-year-olds but still high among the 22-25-year-olds, thus not supporting a strong
period effect. (Table 17)
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Table 18. Patients excluded from the analyses because of onset 
before 16 years or lacking age at onset
Cohort Excluded
Age at onset Disability pension, Free medication, 
<16 years1 no hospitalization2 no hospitalization3
 (No.) (No.) (No.)
1954-1955 46 113 60
1956-1957 51 88 29
1958-1959 35 63 36
1960-1961 40 64 24
1962-1963 44 51 20
1964-1965 44 51 12
1First diagnosis of schizophrenia before 16th birthday
2Disability pension because of schizophrenia granted before 26th birthday, 
no hospitalizations
3Free medication but no hospitalizations nor disability pension because 
of schizophrenia
The number of patients who had received disability pension because of schizophrenia
before their 26th birthday but had no hospitalisations decreased in successive cohorts, as
did the number of patients with free medication because of schizophrenia but without
hospitalizations or disability pension. The number of patients with childhood-onset
schizophrenia was stable, but we lacked information concerning the youngest age
groups from the cohorts born in the 1950s. (Table 18)
The proportion of patients diagnosed with schizophrenia in their first admission
decreased from 77% in the first to 70% in the last cohort. The incidence of other
nonaffective psychotic disorders rose from 0.13 to 0.19 per 1000 between the first and
last cohorts.
5.4. Time trends in the seasonal variation of births in schizophrenia
Of the 16 687 patients with schizophrenia born between 1950-1969, 15 398 had at least
one hospital treatment because of schizophrenia, and 872 received disability pension but
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had no hospitalizations because of schizophrenia. There were 417 patients excluded
because they only had free medication but no hospitalization or disability pension for
schizophrenia. In addition, 378 patients had to be excluded because of missing values
for some of the variables. Thus, the final sample consisted of 15 892 patients.
Table 19. Incidence and relative risk of schizophrenia according to month and  
place of birth in Finnish birth cohorts born in 1950-1969
Variable
Incidence 
per 1 000
Relative 
risk
95% CI χ2 d.f. P 
Month January 0.48 1.00 - 22.2 11 0.02
of Birth February 0.47 0.99 0.92-1.07
March 0.43 0.91 0.84-0.98
April 0.46 0.96 0.90-1.04
May 0.44 0.93 0.86-1.00
June 0.44 0.93 0.86-1.00
July 0.45 0.94 0.87-1.01
August 0.42 0.88 0.81-0.95
September 0.43 0.89 0.83-0.96
October 0.44 0.92 0.85-0.99
November 0.43 0.91 0.84-0.98
December 0.45 0.95 0.88-1.02
Place Rural 0.45 1.00 - 29.2 1 <0.001
of Birth Urban 0.40 0.89 0.85-0.93
In the unadjusted analysis, incidence was highest among those born in January,
February, April, and December, and higher among the rural-born than the urban-born
(Table 19). In the Poisson regression analysis, the main effects of sex, age at onset,
place of birth, birth cohort, and trend were all significant. A significant interaction was
observed between trend and place of birth: the incidence of schizophrenia declined more
slowly among the urban than the rural born. The main effect of the first harmonic of the
seasonal variation was almost significant, and highly significant two-variable
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interactions between the first harmonic and the birth cohort and the age at onset were
observed. The higher harmonics and their interactions were not significant.
To analyse the interactions further, the unadjusted analysis and the Poisson regression
analysis including the first harmonic of the seasonal variation were conducted
separately for each cohort and age group. Among the birth cohort 1950-1954, the peak
relative incidences were observed between November and January. Compared with
January, December showed a relative incidence of 1.04, and the other months relative
incidences between 0.92 and 0.98. Seasonal variation of births in the 1955-1959 birth
cohort was considerable. The relative incidence was, compared with January, highest in
February, 1.01. The relative incidences in all the other months varied between 0.74 and
0.85, being lowest between August and November. The cohorts born between 1960 and
1964 also showed a seasonal variation of births, although this was less consistent than in
the cohorts born in the 1950s. The most consistent elevations in relative incidence were
observed between February and June. In the birth cohort born between 1965 and 1969,
the peak relative incidences were observed in April and October, and the largest deficit
in November. The most consistent seasonal variation was the late summer deficit.
Among patients with age at onset between 16 and 20 years and 26 and 30 years, there
was a marked winter-spring excess of births, January being the peak month. Among
those with onset between 21 and 25 years, January was a deficit month but otherwise
there was also a winter-spring excess of births. Although January was the peak month
among those with onset between 31 and 35 years, they otherwise showed an autumn
excess and spring deficit of births, as did patients with age at onset over 35 years.
 In the STL decomposition, there was an overall declining trend in the incidence of
schizophrenia. The amplitude of the seasonal variation increased from the beginning of
the 1950s, and a marked seasonal variation was observed in the middle to late 1950s,
followed by a rapid decrease. In the 1960s, the amplitude of the seasonal variation was
smaller than at the beginning of the 1950s. The residuals from the model were still
rather large, suggesting that other sources of variation in the incidence besides trend and
seasonal variation also existed.
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6. DISCUSSION
This study was based on a nationwide population of nearly all treated patients with
schizophrenia born in the 1950s and 1960s, and their first-degree relatives. Patients
were ascertained from three independent registers. Our main findings were that the
incidence of schizophrenia declined in birth cohorts born from 1954 to 1965, and this
decline was caused by both cohort- and period related factors. The incidence was higher
among the rural-born, but it decreased more rapidly than among the urban-born.
Concurrently, the magnitude of the seasonal variation of births among future patients
with schizophrenia decreased. One candidate that might explain part of the observed
decline in incidence and decrease in magnitude of the seasonal variation was the
elimination of the polio virus from Finland: second-trimester exposure to polio virus
epidemics was found to be associated with an increased risk of the later development of
schizophrenia. We also observed that high familial loading for schizophrenia was
associated with early onset and poor outcome of schizophrenia, but not with increased
mortality. In the following, methodological issues and the findings in each of the
publications are discussed in detail.
6.1. Methods and methodological limitations
During the last three decades, case registers have become an invaluable tool in
psychiatric epidemiology, increasingly being used in Finnish research, too (Aro et al
1995, Hovatta et al 1997, Isohanni et al 1997, Korkeila et al 1998, Korkeila et al 1998a,
Cannon et al 1998, Cannon et al 1999). The use of registers in obtaining data for cohort-
and case-control studies offers several advantages. Firstly, it is possible to obtain much
larger data sets than by any other method. For many rare events such as the occurrence
of cancer among patients with schizophrenia, register epidemiology offers the only
possibility for meaningful research. Registers are also the best method for choosing
representative samples for studies, whereas those based on the patient population in a
given hospital at a given moment, for example, are usually biased toward more
chronically ill patients. Registers can also be used to select representative samples of
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patients for more detailed studies, for example, multiply-affected families for genetic
studies. (Mortensen 1992)
The use of registers is not without limitations, however. The first concern relates to the
accuracy of the data – is every hospital treatment reported to the register, and are the
data from hospital case notes transferred accurately into the register? The accuracy of
data on psychiatric diagnoses in the Finnish Hospital Discharge Register was studied in
1986 and found to be excellent; when entries in the register were compared with data on
hospital case notes, the primary diagnosis in the register and hospital case notes was
identical in 99% for schizophrenia and in 98% for all mental disorders, and the dates of
admission and discharge were identical in 96% of the cases (Keskimäki & Aro 1991).
The information in the Pension and Free Medicine Registers is accurate because
payment of these benefits is based on the registers.
The second concern in the study was the reliability of the register diagnoses of
schizophrenia, which are inevitably of variable quality. The reliability of schizophrenia
diagnosis in the Hospital Discharge Register has been assessed in several studies. In a
study of first-contact patients with schizophrenia or schizophreniform disorder in
Helsinki in 1975, only 52% of the patients who received a DSM-III diagnosis of
schizophrenia or schizophreniform disorder had received a hospital discharge diagnosis
of schizophrenia or schizophreniform disorder (Kuusi 1986). In another study of all first
admissions to the two mental hospitals in Helsinki in 1981, 35% of the patients received
a diagnosis of schizophrenia (S+) or borderline psychosis (O+) as assigned by the
CATEGO computer program based on a Present State Examination interview, but only
19% had received a clinical diagnosis of schizophrenia or schizophreniform disorder
(Pakaslahti 1987). Salokangas also observed in an incidence study covering six health
care districts in Finland that clinicians made a DSM-III diagnosis of schizophrenia less
often than an independent researcher (Salokangas 1993). Isohanni et al compared
clinical and research DSM-III-R diagnoses of schizophrenia in the Northern Finland
1966 birth cohort and found 71 patients fulfilling DSM-III-R criteria for schizophrenia;
only 37 of them had a register diagnosis of schizophrenia (Isohanni et al 1997). In a
sample of patients from one municipality, 87% of patients with a schizophrenia
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diagnosis and 18% of patients with a schizophrenia spectrum diagnosis in the register
fulfilled DSM-III-R criteria for schizophrenia (Mäkikyrö et al 1998). Cannon et al
found 92% agreement (κ=0.84) between the register diagnosis of schizophrenia and an
interviewer’s DSM-III-R diagnosis in 72 randomly selected probands and 43 of their
siblings born in Helsinki from 1950 to 1958 (Cannon et al 1998). These studies indicate
that Finnish psychiatrists tend to apply a narrow definition of schizophrenia in their
clinical practice and that the register diagnosis of schizophrenia can be considered
reasonably reliable, although our results concerning the incidence of other nonaffective
psychotic disorders suggest that slight narrowing in the clinical concept of
schizophrenia has occurred.
Our incidence calculations were based on the number of persons alive in each of the
birth cohorts defined by sex and year, month, and place of birth at the end of 1969, and
the yearly number of deaths between 1970 and 1991. This method did not allow us to
correct for all the effects of migration. While the Finnish population during the 1950s
and 1960s was considerably more stable than in most other countries, with negligible
immigration, emigration from Finland was much more common. Before World War
Two, most emigration was to the United States and Canada. Interestingly, all the US
states favoured by Finns (Michigan, Minnesota, New York, Massachusetts,
Washington, California and Wisconsin) (Korkiasaari 1989) had a high prevalence of
insanity at that time (Torrey & Bowler 1990). After the war, emigration shifted toward
Sweden; between 1954 and 1991, 440 000 Finns moved to Sweden, while emigration to
other countries was negligible (Institute of Migration 1999). During the same years,
however, 250 000 persons moved from Sweden to Finland, and almost all were
returning Finns (Institute of Migration 1999). More than half of the immigrants living in
Sweden were still Finnish citizens (Korkiasaari 1989) and remained in Finnish registers.
It was thus impossible to correct for all the effects of migration, although we excluded
persons born outside Finland from the study, and those born in Finland who have
moved abroad permanently are not included in any of the registers. To our knowledge,
no studies of the incidence of schizophrenia among Finnish immigrants in Sweden have
been published. However, the rate of suicide among them is higher than that in Finland
(Ferrada-Noli et al 1995). Immigrants from these cohorts may have had more
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psychiatric morbidity than those who stayed in Finland, but most of those who remained
Finnish citizens were returned to Finland if longer periods of psychiatric treatment were
needed. Therefore, we believe that migration was not a major confounder in the study.
As the true age at onset was not known, it was approximated by using the age at the
onset of first hospitalisation for schizophrenia or for any psychotic disorder. "Any
psychotic disorder" included in the first publication alcohol- and substance-induced
psychotic disorders, which may have resulted in defining the age at onset of those cases
whose first hospitalisation was caused by such disorders too early. In the majority of the
cases, both definitions overestimate the true age at onset.
In the fourth publications, one of the variables of interest was urban vs. rural birth.
Urban birth was defined as having been born in Helsinki, Tampere, and Turku, which
were the only towns in Finland with more than 50 000 inhabitants at the beginning of
the 1950s, and all already had over 100 000 inhabitants. The definition is comparable to
“city birth” in other studies (Lewis et al 1992, Mortensen et al 1999). There clearly were
other urban areas in Finland in the 1950s and 1960s. However, urbanization was rapid
between 1950 and 1969, and the population in many towns increased severalfold. By
1969 there were eleven towns with more than 50 000 inhabitants. Population density in
each area in each year would have been more informative than the simple
dichotomization used, but unfortunately such information was not available. However,
the effect of urbanization has been shown to be strongest in highly densely populated
areas (Verdoux et al 1997, Marcelis et al 1998, Mortensen et al 1999). Few areas other
than Helsinki, Tampere, and Turku would have been thus classified in Finland.
The statistical methods used in the study have been extensively used and validated. The
only method yet to be established was the familial loading score, used to quantify
familial loading. One of the major problems in using the familial / sporadic distinction
is the misclassification problem. If families are small and relatives young, a proband
may be mistakenly classified as sporadic because of lack of sufficient follow-up
information from the family (Roy & Crowe 1994). Familial loading score was designed
to be “a simple extension of the family history positive-negative dichotomy to take
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account of family size and age structure” (Verdoux et al 1996). It has been used in a
number of recent studies (Verdoux et al 1996, Van Os et al 1997, Cannon et al 1999).
However, we found its use as a continuous variable problematic: it cannot solve the
problem of misclassification in small families. It is still impossible to classify a proband
who is an only child as familial or sporadic; the same applies in families with one
affected and 1-3 unaffected siblings. However, we found the familial loading score a
useful method to identify families with the smallest familial loading. For example, if a
proband aged 18 is the oldest child in family with 12 children, we still know nothing
about his familial risk, but if he is the youngest, we know considerably more. In such
families, the familial loading score works as it is meant to: it places the families in
correct order according to their size and age structure, and is thus a feasible method for
identifying the most and least familial probands.
The strengths of this register-based study were the nationwide, representative patient
population, the identification of patients from three independent registers, the
availability of family information, and the availablity of population information
enabling the calculation of exact person-years at risk.
With these methodological assets and limitations in mind, findings from each of the
publications are discussed further in the following.
6.2. The effect of familial loading on the age at onset and outcome
We used the familial vs. sporadic, or high vs. low familial loading, research strategy to
investigate whether the degree of familial loading has any effect on the age at onset and
outcome of schizophrenia. The study was motivated by the controversies provoked by
previous research findings. While studies conducted before 1994 found no differences
in the age at onset in familial and sporadic schizophrenia (Roy & Crowe 1994), two
recent investigations have observed an earlier onset in familial schizophrenia (Albus et
al 1994, Alda et al 1996). Consistently with this, relatives of early-onset probands have
had a higher risk of schizophrenia in several studies (Kendler & MacLean 1990a, Maier
et al 1993, Sham et al 1994). In addition, several others have found that the later onset
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among females is confined to sporadic schizophrenia, while no sex differences exist in
familial schizophrenia (Shimizu & Kurachi 1989, Albus et al 1994, Murphy et al 1994,
Gorwood et al 1995). Previous studies found no association between outcome and
familiality, but Verdoux et al noted high familial loading to associate with poor
outcome (Verdoux et al 1996). We hypothesised that this discrepancy was caused by
too broad definitions of familiality and sporadicity and too small sample sizes in the
earlier studies. Our study benefitted from strict definitions of high and low familial
loading and a large, nationwide, representative sample. Our aim was to discover
whether by using the familial / sporadic distinction it is possible to separate patient
groups that differ in their clinical characteristics.
The intermediate group in our sample consisted of a large spectrum of patients, some of
whom even had a first-degree relative with schizophrenia, while others had quite large
families with no relatives with psychotic disorders. The intermediate group could thus
be regarded to represent schizophrenia in general. The familial group consisted of
patients with at least two first-degree relatives with schizophrenia, making it reasonable
to assume that their disease was more genetic than in the majority of patients. The
sporadic group consisted of patients from very large families with no other first-degree
relatives suffering from schizophrenia, who thus probably had a less genetic form of the
disorder than those in the other groups.
As in other recent research, we found that familial schizophrenia is associated with early
age at onset and sporadic with later. We found no sex differences in age at onset in the
whole sample, which is consistent with previous Finnish research (Kuusi 1986,
Salokangas 1993, Hovatta et al 1997). Both females and males with sporadic
schizophrenia had a later age at onset, while in most previous studies only females with
sporadic schizophrenia had a later age at onset (Shimizu & Kurachi 1989, Albus et al
1994, Murphy et al 1994, Gorwood et al 1995). However, females with sporadic
schizophrenia seemed to consist of two separate groups, one with similar age at onset to
females in the intermediate group, and another with later age at onset. This latter group
would be especially interesting to study further, because it might reveal aetiologic
heterogeneity.
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Females with familial schizophrenia had a slightly earlier onset than males. Some
previous studies have observed that relatives of female early-onset patients have an
increased risk of schizophrenia compared with relatives of later-onset females or early-
or later-onset males (Sham et al 1994a); our findings support this. It may also be that
high familial loading decreases the age at onset only among females. This would lead to
the disappearance of the age-at-onset difference between males and females in countries
where females usually have a later age at onset, and an earlier onset in familial females
in our sample where no sex difference existed in the age at onset in the first place.
However, the age-at-onset difference between males and females in the familial group
was very small - only one year.
The correlation of age at onset between affected siblings was remarkably similar to that
found in previous studies (0.28 vs. 0.24-0.26) (DeLisi et al 1987, Kendler et al 1987,
Burke et al 1996, Cardno et al 1998 ). The correlation between siblings suggests that
age at onset is partly under genetic control, making it one possible phenotypic marker to
be used in genetic studies (Cardno et al 1998a). Genetic loci contributing to the
variation in the age at onset of schizophrenia were searched for in a recent genome scan
and tentative evidence for linkage was found on chromosome 17q (Cardno et al 1998).
Familial schizophrenia was associated with longer and sporadic schizophrenia with
shorter annual duration of hospitalisation. Familial schizophrenia was also associated
with a higher risk of receiving a disability retirement pension. The findings are in
accordance with those of Verdoux et al, who found an association between poor
outcome and high familial loading (Verdoux et al 1996).
This study suggests that by using very stringent criteria of familiality and sporadicity it
is possible to ascertain groups of patients that differ in the severity of schizophrenia.
However, this would also be suggested by the multifactorial polygenic model, which
predicts that the more predisposing genes an individual has, the more severe is the
illness (Gottesman & Shields 1982, p. 224). Whether there is any difference in the
underlying aetiological mechanisms remains for future studies to reveal.
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No association between familial loading and mortality was found. Mortality was
significantly lower among females, and later age at onset was associated with higher
mortality. Overall mortality in this group of relatively young patients was high: 13.6%
among females and 17.6% among males. In a Danish study, the mortality after the first
five years of the first diagnosis of schizophrenia was 11.1% among females and 11.9%
among males (Munk-Jørgensen & Mortensen 1992), which is comparable to our finding
because the follow-up time among the majority of patients in our study was
considerably longer than 5 years, although they were younger. Munk-Jørgensen and
Mortensen found that mortality increased from the 1970s to 1980s. While the causes of
death were not analysed in the present study, our results clearly indicate the need for
further studies of the mortality of patients with schizophrenia in Finland, especially the
proportion of deaths due to suicide and possible time trends.
6.3. Prenatal exposure to polio epidemics
We observed that second-trimester exposure to polio epidemics increased the risk of the
later development of schizophrenia modestly but significantly. The relatively small
effect of the exposure is unsurprising given that genetic factors are most important in
the etiology of schizophrenia and that several other possible environmental risk factors
have already been identified. It may also be that we lacked statistical power. The timing
accords with previous findings of a neurodevelopmental insult in schizophrenia during
the second trimester of fetal life (Huttunen et al 1994).
That the effect did not increase with the severity of exposure might be because we
restricted ourselves to the incidence of paralytic poliomyelitis. Paralytic symptoms
develop in less than 1% of those infected with the polio virus and only after an
incubation period of up to one month (Nathanson & Martin 1979). In addition, the
case:infection ratio depends on age, level of immunity in the population, and the type of
poliovirus (Nathanson & Martin 1979). There are three virus types of polio virus, type 1
being the most virulent and type 2 the least (Nathanson & Martin 1979).
106
The first field trial of a polio vaccine in Finland was conducted during a large
poliomyelitis epidemic in 1954. A large number of 6-12-year-old children were
recruited, half of whom were vaccinated while the other half served as controls. Their
antibody status was measured before the vaccination, and again after the termination of
the epidemic. At the baseline, 61% of children had antibodies against Type 1 virus, 44%
against Type 2 virus, and 62% against Type 3 virus. The epidemic was caused by a
Type 1 virus, against which the vaccine did not protect. After the epidemic, 25% of the
originally seronegative subjects had developed antibodies against the Type 1 virus,
regardless of whether they had received the vaccination or not. During the epidemic, the
incidence of paralysis among those acquiring the infection increased from 1 per 250 to 1
per 110. Serologic results were available from 65 cases with paralytic poliomyelitis: 64
cases were caused by Type 1 virus, one by Type 2 virus. (Penttinen & Pätiälä 1961)
According to the findings of Penttinen and Pätiälä, the susceptible population in the
1954 epidemic was considerable, although more than half of the 6-12-year-old children
already had antibodies against Type 1 and Type 3 strains. The seroconversion rate
among the susceptible population was also high: the epidemic was widespread. It seems
reasonable to assume that during an epidemic like this, a significant proportion of
pregnant women (although clearly less than half) belonged to the susceptible population
and a significant proportion of those belonging to the susceptible population also got the
infection. The findings also suggest that the virulence of the virus may change even
during one epidemic.
The association between prenatal exposure to polio virus and adult schizophrenia might
be limited to one of the serotypes. Or it might be confined to one exceptionally virulent
form of one of the serotypes. Thus, it would have been interesting to study the
association according to the type of virus that had caused the epidemic in each of the
years, but unfortunately the information was not available.
We are left with many unanswered questions. An ecological study cannot prove causal
association. For this, a follow-up study of pregnant women who actually had polio virus
infection during the 1950s would be needed. The type of polio virus which caused the
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infection should also be known. While such a study might be almost impossible to
conduct, our results encourage research on other enteroviruses, which in many respects
are similar to polio viruses and have become the most common viral agents causing
aseptic meningitis (Muir & van Loon 1997).
6.4. Changes in the incidence
The incidence of schizophrenia in the 16-25 year age groups was higher than in the
WHO Ten Country Study, where incidences of the same magnitude among the 15-24-
year-olds were observed only in a few areas and using broadly defined schizophrenia
(Jablensky et al 1992). However, previous Finnish studies have obtained similar results:
the cumulative incidence of DSM-III-R schizophrenia up to 28 years was 0.69% in the
northern Finland 1966 cohort (Jones et al 1998), and the incidence of all psychotic
disorders in a study conducted in the 1980s varied between 0.49 and 0.88 per 1000
person years among the 15-24-year-olds (Salokangas et al 1987).
Our method differed from other studies, except that from south Verona (Balestrieri et al
1997), because we examined birth cohorts, while others investigated patients admitted
for the first time in a defined period. The results suggest that the incidence of
schizophrenia has declined. We found no sex differences, while others have found a
greater decline in women (Strömgren 1987, Geddes et al 1993, Waddington & Youssef
1994, Takei et al 1996) or in men (De Alarcon et al 1990, Munk-Jørgensen &
Mortensen 1992, Balestrieri et al 1997). The decline was of the same magnitude as that
observed in previous European studies (Strömgren 1987, Munk-Jørgensen 1987, Eagles
et al 1988, Der et al 1990, De Alarcon et al 1990, Munk-Jørgensen & Mortensen 1992,
Geddes et al 1993, Waddington & Youssef 1994, Takei et al 1996, Brewin et al 1997,
Balestrieri et al 1997). A recent Finnish study based on first admissions of all
nonaffective psychotic disorders in 1990 and 1993 also found a decline in the first-
admission rate (Korkeila et al 1998); however, this was actually not the true rate,
because first admission was defined as having no hospitalisation during the three
previous years (Korkeila et al 1998).
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In accordance with the Scottish age-period-cohort analysis (Takei et al 1996), we found
that the effects of period and cohort on the decline were both significant.
6.4.1. Cohort-related factors
The significant birth cohort effect suggests that the frequency or intensity of one or
more risk factors involved in the etiology of schizophrenia, probably operating early in
life, has decreased – or that the intensity or frequency of some protective factors has
increased. Both genetic and environmental risk factors may change over time.
The Finnish population was relatively isolated for centuries. Genetic isolation may be
the reason for pockets of exceptionally high prevalence of schizophrenia (3-4%) in rural
eastern and northern Finland (Hovatta et al 1997). Migration from rural to urban regions
increased rapidly after World War II, and marriage between persons from different parts
of Finland became more common. In our sample, the proportion of patients with parents
born in the same municipality fell from 30% in 1954 to 23% in 1965. This may have
caused the incidence to decline, if genes predisposing to schizophrenia had become
enriched in some areas of Finland. It has also been suggested that schizophrenia could
be associated with decreased developmental stability caused by genetic homogeneity
(Markow 1992). If so, increasing genetic heterogeneity caused by migration inside
Finland could have resulted in a decline of the incidence of schizophrenia. However,
when the hypothesis suggesting that decreasing isolation might cause the rare autosomal
recessive diseases of the Finnish Disease Heritage to disappear was tested using the
incidence of congenital nephrotic symptoms, no evidence for decline in the incidence
was observed (Laakso et al 1992).
Public health care in Finland improved substantially from 1954 to 1965, reflected in a
dramatic decrease in infant and maternal mortality and an increase in hospital deliveries
from 75 to 99 per cent (Official Statistics of Finland 1972). Because obstetric
complications are a risk factor for schizophrenia (Geddes & Lawrie 1995), these
improvements may have affected the incidence of schizophrenia.
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Infections are also a possible explanation for the observed cohort effect. Polio virus was
eliminated from Finland in the beginning of the 1960s (Nathanson & Martin 1979), but
large epidemics occurred in the 1950s, and as we have shown, second trimester
exposure to polio epidemics may increase the risk of developing schizophrenia. Another
possibility is influenza: three large influenza epidemics occurred in 1953, 1955, and
1957. The decreasing seasonal variation of births after very pronounced seasonality in
the mid 1950s suggests that a reduced intensity of some seasonally varying
environmental risk factor might be involved in the decline of incidence.
6.4.2. Period-related factors
The effect of period on the incidence of schizophrenia was significant. Period effects
reflect the impact of risk factors operating in adult life which affect several or all age
groups simultaneously. For example, suicide rates in England declined in all age groups
during World War II, and also in the 1960s after the detoxification of domestic gases
(Murphy et al 1986). In schizophrenia, period-related risk factors are not known and it
seems more likely that the significant period effect found in the present study reflects
artifacts caused by period-related confounding factors.
Register information reliability may change over time. Registers not using personal
identification numbers usually have a code for first admissions, which has been used in
several previous register-based studies and found to be rather unreliable (Kendell et al
1993). We avoided this problem. The incidence of schizophrenia may also appear to
change if the proportion of persons with schizophrenia who never seek treatment
changes. However, the proportion of schizophrenic patients who never receive
psychiatric treatment in Finland is small: in a health survey based on a nationally
representative sample of 8000 persons carried out in 1978-1980, 99% of persons with a
psychotic disorder had received psychiatric treatment (Lehtinen et al 1991).
The proportion of schizophrenic patients treated exclusively as outpatients may change
(Kendell et al 1993). The Finnish psychiatric health care system has undergone
considerable changes. The number of beds in psychiatric hospitals peaked at the
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beginning of the 1970s (Salokangas 1994), and since 1982 the number of beds has been
decreasing rapidly (Korkeila et al 1998). Although a shift toward outpatient treatment
could have occurred at the same time, the numbers of patients on disability pension or
free medication for schizophrenia but never hospitalized did not indicate any rise in the
proportion treated solely as outpatients. The situation would probably have been
different in the 1990s: acute psychosis teams, which treat psychotic patients with
intensive outpatient treatment and aim at avoiding inpatient treatments unless necessary,
have been established in nearly all health care districts (Tuori et al 1998). The decrease
in the number of beds in psychiatric hospitals was also rapid in the beginning of the
1990s (Korkeila et al 1998). However, the overall rate of patient admissions in
psychiatric hospitals remained the same in 1990 and 1993, although there were 4540
fewer beds available in 1993 (Korkeila et al 1998). Thus, the use of hospital care is not
determined solely by the availability of hospital beds (Korkeila et al 1998).
Narrowing of the diagnostic concept of schizophrenia explained a significant proportion
of the decline in the incidence of schizophrenia in Edinburgh (Kendell et al 1993).
Although Finnish psychiatrists tend to apply a narrow definition of schizophrenia in
their clinical practice (Pakaslahti 1987, Salokangas 1993, Isohanni et al 1997, Cannon et
al 1998), with more tendency to false negative than false positive diagnoses, diagnostic
criteria changed in Finland in 1987 when DSM-III-R criteria were adopted for clinical
use. We observed a subsequent significant increase in the incidence of other
nonaffective psychotic disorders. Although the numbers were small, a diagnostic shift
from schizophrenia to these diagnoses could explain some of the observed decline in
schizophrenia incidence. The rise in the incidence of other nonaffective psychotic
disorders also reflected the increased diagnostic delay, partly caused by shorter hospital
admissions (Tuori et al 1998) in the 1980s: the proportion of schizophrenic patients who
were so diagnosed in their first admission decreased from 77% in the first to 70% in the
last cohort. Thus, a narrowing clinical concept of schizophrenia at least partially
explains the observed period effect.
If the age at onset or the time lag between the onset of first symptoms and the beginning
of first hospitalisation changes, age-specific incidences may alter without any change in
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the overall incidence (Kendell et al 1993). No increase in the age at onset was observed
in this study; on the contrary, the peak of highest incidence shifted toward an earlier
age. The time lag between the onset of first symptoms and first hospitalization has been
assessed in studies of first-admission patients conducted quinquennially in the Helsinki
area (Achté et al 1986). Although the lag has varied somewhat over the years, being
longest in the 1965 and 1970 cohorts, no major changes that could explain the observed
decline in the incidence have occurred (Achté et al 1986).
6.4.3. Age-period-cohort analysis
The age-period-cohort analysis method we used is widely accepted and produces
reliable estimates (Holford 1991, McNally et al 1997, Robertson & Boyle 1998).
However, it assesses only deviations from linearity, i.e., curvature effects, while the
effects of period and cohort in any steady, linear changes remain unexplained. Because
of this, the effects of period and cohort we observed should not be interpreted as the
total effects of cohort and period on the incidence. Nevertheless, curvature effects
provide valuable information, because many changes in cohort-related factors, e.g.
infections, and period-related factors, e.g. changes in diagnostic criteria, are abrupt in
nature and should cause deviations from a linear trend. Another possibility would have
been to use some constraint to ensure identifiability of the linear component of the
effects. However, the use of such constraints is acceptable only if they are based on
sound theoretical grounds, which is usually not the case (Robertson & Boyle 1998). The
effect of using such constraints is marked, and usually the results obtained are not
considered reliable (McNally et al 1997, Robertson & Boyle 1998). Therefore, we felt it
was safer to a use method that produces reliable, albeit conservative, estimates
(McNally et al 1997).
Based on the results of our study it seems reasonable to conclude that the age-specific
incidence of schizophrenia among persons aged 16 to 25 years in Finland has decreased.
A significant cohort effect was observed, suggesting that some risk factors for
schizophrenia, probably operating early in life, have diminished in intensity. The effect
of period was also significant and probably reflects changes in diagnostic criteria. The
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findings from this cohort-based study accord with those of several period-based studies,
thus strengthening evidence of a worldwide decline in the incidence of schizophrenia.
More detailed studies on cohorts born in the 1950s and 1960s that focus on risk factors
of schizophrenia may reveal causes of the decline. Such studies are currently being
conducted in Helsinki (the Helsinki 1951-1960 Birth Cohort) (Cannon et al 1999) and in
Oulu (the Northern Finland 1966 Birth Cohort) (Isohanni et al 1996).
6.5. Time trends in the seasonal variation of births in schizophrenia
We observed that seasonal variation in schizophrenic births in the 1950s was prominent,
but it decreased considerably in the 1960s. We failed to detect any interaction between
place of birth and seasonality, implying that urban birth is not associated with season of
birth in Finland. However, we did observe an interaction between place of birth and
trend: the incidence of schizophrenia declined more slowly among the urban born
population. In line with most previous studies (Torrey et al 1997), no interaction
between sex and season of birth was observed. The decline in the incidence of
schizophrenia coincided with the decrease of seasonality in schizophrenic births. It may
be, as suggested by Procopio and Marriott, that some of the decline in the incidence was
caused by a disappearance or diminishment of a seasonal aetiological agent (Procopio
and Marriott 1998). The factor might be an infection, as discussed earlier.
The availability of detailed and reliable register information allowed us to construct
historical birth cohorts and to use accurate person-years to calculate the incidence of
schizophrenia. We were thus able to control for the association between season of birth
and mortality in the general population. Postneonatal deaths, especially those caused by
infections and sudden infant death syndrome, show a marked seasonality with a peak
during winter (Peterson et al 1979, Hare et al 1981, Apostolidou et al 1994). Previously,
perinatal mortality has also shown similar seasonal variation (Timonen et al 1968,
Rantakallio 1971, Hare et al 1981). The seasonal variation of perinatal deaths
diminished in England and disappeared completely by 1965 (Hare et al 1981), but still
existed in the Northern Finland 1966 Birth Cohort (Rantakallio 1971).
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Our finding of declining seasonal variation contradicts the findings of two recent studies
which found either no change (Procopio & Marriott 1998) or an increase (Eagles et al
1995) in the seasonality of births. However, we avoided some possible sources of bias
by using entire birth cohorts as the study population. The study in England and Wales
was based on all hospital treatments during one year and included patients born between
1938 and 1977 (Procopio & Marriott 1998). The probability of admission in a given
year may not be unrelated to the season of birth, because mortality in the general
population may be associated with season of birth and because seasonal variation of
births in schizophrenia may be associated with the severity of the illness (Torrey et al
1997). In the Scottish study, the study sample was selected from first contacts between
1962 and 1987 and included patients born between 1900 and 1969 (Eagles et al 1995).
Thus, only very late-onset cases could have been identified from the earliest cohorts.
Relatives of patients with very late-onset schizophrenia do not have an increased risk of
schizophrenia, suggesting that very late-onset and earlier-onset schizophrenia may not
be genetically linked (Howard et al 1997). Cases from the oldest cohorts might not then
be suffering from exactly the same disorder as the others. Another limitation in the
Scottish study was that population information was not available. In Finland, the
seasonal variation of general births shifted during the 20th century from a summer peak
before World War II (Lagerqvist & Niemineva 1949) to a spring peak since the 1950s.
If a similar shift occurred in Scotland, this might have caused the observed increase in
the odds ratio for winter/spring births.
Another puzzling finding was the considerable seasonal variation between 1955 and
1959. The overall variation in the relative incidence was almost 30%, the incidence of
schizophrenia was higher in each of the months between December and April than in
any other, and the relative incidence was quite low, 0.74-0.79, between July and
November. This variation was much more marked than the usually cited 5-8% winter-
spring excess (Torrey et al 1997). Unfortunately, few previous studies covering the
1950s and 1960s reported the amplitude of the seasonal variation separately for different
birth cohorts. Eagles et al found an increased ratio of births between December and May
compared with June and November in the 1950s, but the increase was confined to males
and was even more pronounced in the 1960s (Eagles et al 1995). However, a recent
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Japanese study of seasonal variation of births among patients born between 1955 and
1960, excluding those born between June 1957 and May 1958, found an 10% excess of
births in the winter, and a 14% deficit of births in the summer (Kunungi et al 1997),
which is almost comparable to our findings.
Influenza and polio epidemics together might at least partly explain the observed pattern
of seasonal variation. Two of the largest epidemics of poliomyelitis in Finland occurred
in 1954 and 1956, and the incidence of paralytic poliomyelitis was also high in 1955,
1959, and 1960. The highest numbers of influenza cases during the 1950s were reported
in 1957, 1953, and 1955 - more in each of these epidemics than in any that occurred
during the 1960s. Other possible explanations for the decreasing seasonal variation
might be decreased exposure to cold temperature during pregnancy because of
improved living conditions. Also the seasonal variation of obstetric complications
observed in the 1950s birth cohorts (Timonen et al 1965) might have decreased because
of the improving obstetric care, and this might have caused the seasonal variation of
births in schizophrenia to decrease. However, neither of these hypothesis explain the
observed increase in the seasonal variation in the 1950s.
An interaction between age at onset and seasonal variation was observed: autumn birth
was more common among those aged over 30 years at onset of schizophrenia.
Interestingly, these patients all belonged to cohorts born in the 1950s who otherwise
showed marked winter/spring excesses. Age of onset groups 16-20 years and 26-30
years showed the most prominent winter-spring excesses of births. However, the 1950-
1954 cohort was underrepresented in the age group 16-20 years, and the 1965-1969
cohort in the age group 26-30 years. The study population did not include patients with
onset after 41 years. Although our results suggest an association between early onset
and winter-spring excess of births, far reaching conclusions should not be drawn from
the observation because of the limitations mentioned.
We observed no interaction between seasonal effect and place of birth, which suggests
that the agent causing the seasonality was equally prevalent in the three largest towns
and in other parts of Finland. However, the incidence of schizophrenia was higher in
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rural than urban areas, which accords with findings of higher incidence and prevalence
of schizophrenia in rural eastern and central Finland (Salminen 1975, Salokangas et al
1987, Lehtinen et al 1990, Hovatta et al 1997, Korkeila et al 1998). In the WHO Ten
Country Study, the incidence of schizophrenia was higher in a rural than an urban area
of India (Jablensky et al 1992). In Western countries, the incidence of schizophrenia has
been higher in urban than in rural areas (Freeman 1994), and higher among those born
or brought up in urban than in rural areas (Lewis et al 1992, Verdoux et al 1997,
Marcelis et al 1998, Mortensen et al 1999). It has been suggested that the higher
incidence in urban areas is caused by more crowded living conditions which predispose
to infections during pregancy and childhood (Mortensen et al 1999). It may be that
living conditions in Finland were actually more crowded in rural areas, which could be
one reason for the higher incidence of schizophrenia in rural areas. Another reason
could be genetic isolation (Hovatta et al 1997).
An interesting interaction was observed between overall trend in the incidence of
schizophrenia and place of birth: incidence declined more slowly among the urban than
rural born. Marcelis et al recently found that urban birth increased the risk of developing
schizophrenia more in birth cohorts born in the 1960s and 1970s than in older cohorts
(Marcelis et al 1998). Urbanization began in Finland only after World War II and has
been very rapid. Our findings suggest that the factors in urban living that confer
increased risk of developing schizophrenia may not have existed in Finland until the
1960s, or that the intensity of the factors is increasing. Alternatively, the frequency or
intensity of risk factors of schizophrenia may have been decreasing in rural areas.
6.6. Implications for further studies
This study is a part of an ongoing research project on the epidemiology and aetiology of
schizophrenia. The aim of the study was to use register data to identify research
methods, candidate risk factors, and time periods in which risk factors for schizophrenia
may have changed quantitatively or qualitatively. This information can be used in the
planning of more targeted research.
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The aim of the first publication was methodological. The familial / sporadic
schizophrenia distinction was originally proposed as a research strategy to separate
patients with more genetically caused (familial) or more environmentally caused
(sporadic) disease (Lewis et al 1987). The method has attracted much criticism, partly
due to the misunderstanding that a sporadic case is equal to a phenocopy (McGuffin et
al 1987, Roy & Crowe 1994). The method also has its supporters, however, who
consider it a useful strategy together with family, adoption, and twin studies in the
identification of genetic and environmental risk factors for schizophrenia (Kremen et al
1992). In 1994, Roy and Crowe reviewed all studies using the distinction. They found
no evidence of differences in any clinical features between the familial and sporadic
groups, and only a few differences in vulnerability indicators. However, they concluded
that “the scarcity of studies with adequate methodology precludes any definite
judgement about the validity of the familial-sporadic distinction” (Roy and Crowe
1994). Roy and Crowe set criteria for future studies using the distinction, and they
stressed two aspects: stringent definitions of familiality and sporadicity, and adequate
sample size. This study used stringent definitions of both familiality and sporadicity,
and the sample size was over 10 times larger than in any of the previous studies. We
have shown that using stringent definitions it is possible to identify familial and
sporadic groups that differ in their age at onset and outcome. Interesting sex differences
also emerged. In the future, these patients should be personally contacted to study
vulnerability indicators in these groups and their relatives. Another implication for
future research is that age at onset of schizophrenia can be used as one method to
classify phenotype in genetic studies.
We found an association between second trimester exposure to polio virus epidemics
and adult schizophrenia. Our findings add to the existing evidence that adverse events
during the second trimester of fetal life increase the risk of developing schizophrenia
(Huttunen et al 1994). An ecological study cannot, however, prove a causal association.
In the future, a cohort of mothers who have had polio virus infection during pregnancy
should be traced and followed up, but it is uncertain whether such cohorts exist. It
should also be further clarified whether the association is specific, limited to one
serotype of polio viruses, or more general, extending perhaps to other types of
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enteroviruses as well. Another Finnish study has found an association between neonatal
Coxsackie B5 meningitis and adult schizophrenia. There is strong evidence for
enteroviruses being involved in the aetiology of acute myocarditis and dilated
cardiomyopathy, and one of the suggested mechanisms has been that enteroviruses may
trigger an exaggerated immune response not only to the viral antigens but to the host
tissue (Baboonian & Treasure 1997). There is also evidence that they are involved in the
aetiology of insulin-dependent diabetes mellitus (Hovi 1998), another disease with
known autoimmune background. Compared with these two diseases, the evidence
suggesting that enteroviruses are involved in the aetiology of schizophrenia is scarce,
and further studies are needed. It may be impossible to retrospectively locate cohorts of
persons whose mothers had enteroviral infection during pregnancy. Another, more
feasible alternative is to locate persons who have had an enteroviral CNS infection
during childhood and study the incidence of psychotic disorders among them. If
enteroviruses are shown to be involved in the aetiology of schizophrenia along with
insulin-dependent diabetes mellitus and some heart diseases, there will be an urgency to
develop vaccination against all of them.
The apparent time trends in both the incidence and the seasonality of births imply that
some change in the frequency or intensity of risk factors for schizophrenia occurred
between the 1950s and 1960s. Changes in both genetic and environmental risk factors
could be involved in the decline of the incidence of schizophrenia. However, the
decrease in the seasonality of births might be accounted for more by changes in
environmental than genetic risk factors. These findings imply that cohorts born during
the 1950s and 1960s should be better characterized according to the environmental risk
factors they have experienced. Further studies should attempt to locate cohorts with
reliable exposure information on infections and on pre- and perinatal events. More
detailed studies on geographical variation in the incidence of schizophrenia in Finland,
and on time trends in different regions of the country, are needed to further delineate
areas with large changes in incidence. Such areas, along with those with persistent high
incidence, would be of special interest.
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7. SUMMARY
This study forms a part of the collaborative project “The Genetic Epidemiology and
Molecular Genetics of Schizophrenia in Finland” of the Departments of Mental Health
and Alcohol Research, and of Human Molecular Genetics at the National Public Health
Institute. The aim of the study was to investigate epidemiological features and some risk
factors of schizophrenia among individuals born between 1950 and 1969 who
developed schizophrenia before 1992 (n=16 687). Patients with schizophrenia were
identified using the Finnish Hospital Discharge Register, the Pension Register, and the
Free Medicine Register. Their parents and siblings were identified using the National
Population Register. Schizophrenia was defined as having a 295 diagnosis according to
the 8th and 9th revision notation of the International Classification of Diseases.
Changes in the incidence of schizophrenia were studied among birth cohorts born
between 1954 and 1965. The incidence declined from 0.69 to 0.47 per 1000 person
years. The decline was equal among both sexes and was not caused by changes in the
onset age. The effects of period and cohort on the change were both significant. While
the effect of period reflects the operation of period-related confounding factors such as
the change in diagnostic criteria that occurred in 1987, the cohort effect suggests that
the intensity or frequency of one or more risk factors for schizophrenia has decreased.
Seasonal variation with a significant excess of births during the winter months was
observed among patients with schizophrenia born in the early 1950s. The amplitude of
the seasonal variation increased considerably among patients born between 1955 and
1959 but decreased in the 1960s to a lower level than in the early 1950s. Seasonal
variation of births was not associated with sex and place of birth (urban/rural). A
significant interaction between seasonal variation and age at onset of schizophrenia was
observed: autumn birth was more common among patients aged over 30 years at onset.
The incidence of schizophrenia was higher among the rural-born than the urban-born,
but declined more slowly among the urban-born.
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An association between prenatal exposure to polio virus epidemics and later
development of schizophrenia was observed. Exposure to polio epidemics 5 months
before birth was associated with an increased risk of developing schizophrenia
(RR 1.05, 95% CI 1.00-1.11). When seasonality was omitted from the regression model,
the effect of polioepidemics became significant throughout the second trimester, relative
risks varying between 1.06 and 1.08 4-6 months before birth.
Familial schizophrenia was associated with early age at onset and sporadic with later.
No sex differences in the onset age were found in the whole sample, but females with
sporadic schizophrenia seemed to consist of two groups, one with similar onset age to
females in the intermediate group, and another with later onset. The correlation of age at
onset between affected siblings was 0.28. Familial schizophrenia was associated with
longer annual duration of hospitalisation and sporadic schizophrenia with shorter.
Familial schizophrenia was also associated with a higher risk of receiving a disability
retirement pension. The degree of familial loading was not associated with mortality.
Both the decline observed in the incidence of schizophrenia and the decrease in the
seasonal variation of births among patients with schizophrenia suggest that the intensity
or frequency of one or several risk factors for schizophrenia decreased from the 1950s
to the 1960s. While the risk factors involved could be genetic or environmental, or both,
environmental risk factors seem more likely to explain the decreasing seasonal
variation. The significant association observed between prenatal exposure to poliovirus
epidemics and later development of schizophrenia suggests that the elimination of polio
virus is one possible explanation for the observed changes in the incidence and in the
pattern of seasonal variation. Familial / sporadic distinction may be one useful strategy
in the search for environmental risk factors for schizophrenia. While we showed that
familial and sporadic schizophrenia differ in their clinical picture, further studies should
demonstrate whether they also differ in aetiology.
The results encourage more detailed studies on the early risk factors for schizophrenia
in birth cohorts born in the 1950s. Attention should focus on environmental risk factors,
especially infectious diseases, and on the family history of psychiatric disorders.
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